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ABSTRACT !
In this dissertation, gold catalyst was employed to catalyze intermolecular reactions. 
Intramolecular reactions were far more advanced than intermolecular reaction in gold catalysis. 
With finding suitable ligands for gold catalysts, we were able to develop several transformations 
to synthesize interesting building blocks in organic chemistry including: allenes, furans, spiros, 
oxepines, propargyl ethers and ketones. These functionalities were synthesized by the use of 
triazole-gold(I) catalyst. Triazole, as a ligand bond to gold, showed enhanced stability of the 
catalyst, which resulted in better yields. Gold(I)/(III)  redox chemistry also used for 
cyclopropanol ring openings which resulted in synthesizing substituted ketones. 
! 1!
 !
PART I: TIAZOLE-GOLD CATALYZED PROPARGYL ALCOHOL ADDITION TO 
ALKYNE TO YIELD ALLENES !
Introduction 
Modes of reactivity in gold catalysis 
 
During the last decade, the use of the gold complexes has been increased dramatically.1 
They have been widely used to catalyze reactions involving carbon-carbon multiple bonds. Gold-
catalyzed alkyne hydration reported by Teles initiated this area of chemistry.2 Gold catalysts 
have showed better reactivity toward alkyne activation, when compared with alkene and allene 
functionalities. The most classic mode of reactivity in gold catalysis has been their Lewis acid 
ability (mostly gold III). The most prevalent and developed mode of reactivity has been the π-
acid activation of alkynes, allenes and alkenes. Gold carbenoids has been known as another 
important reactivity of gold complexes.3 The most new-discovered mode has emerged as gold 
redox chemistry which has been exemplified through Au(I)/Au(III) reactions.4 
     
Figure 1: Prevalent modes of reactivity in gold catalysis 
 
Gold (I) π-activation of alkynes has attracted a lot of attention since it allows functionalizing the 
alkynes. Activation of alkynes over alkene made gold a usefully unique metal since alkenes are 
AuIII
L
R2R1
X
AuI
R
L
AuI
L
π-acid acitvation carbeniod Gold(I)/(III) redox
! 2!
known generally as being more reactive than alkynes. 
Upon the activation of alkynes by gold, various nucleophiles have been reported to attack 
to the gold-activated alkyne including: oxygen, nitrogen, sulfur and carbon nucleophiles. 
 
Figure 2: Basic mechanism of gold-catalyzed alkyne activation reactions 
 
The result of the attack of the nucleophile to the alkyne is a vinyl-gold intermediate 
which can undergo several pathways. The most prevalent pathway has been determined to be 
protodeauration, which yielded the functionalized alkene. 
Gold complexes 
 
The gold(I) complexes possess a linear geometry with 180o between the two bonds. As 
shown in the next figure, the L ligand usually is a phosphine or N-heterocyclic carbene. The X 
ligand is a coordinative ligand with a lone pair of electron which can coordinate to the gold. 
When X is neutral, the A as a counter anion can have huge effect on the gold reactivity. The 
reactivity of the gold complexes can be tuned by varying the ligands. Generally the shorter bond 
length of the Au-Ligand, the more stable and less reactive the complex would ultimately be. 
         
[AuI]
Nu: OH, NH2, SH, C
NuH
[Au]
HNu Nu-[Au]
H
L Au X A L Au A + X
! 3!
Figure 3: Basic coordination chemistry of gold complexes 
 
Chemoselectivity 
 
Naked gold cations are considered the most reactive for C-C multiple bond activation. 
They can activate alkynes, alkenes and allenes with very little discrimination. When using 
certain X ligands, X-factor, the gold reactivity will diminish so that the differentiation between 
different C-C multiple bonds will be possible. For example, pyridine, nitrile and triazole are the 
most common X-ligands for this purpose. 
Gold-catalyzed 3,3 rearrangement of propargyl acetates has beed one of the examples in 
which gold chemoselectivity has been observed. As shown in the next figure, when using the 
PPh3AuOTf as a catalyst, the indene product was observed in 92%. While PPh3AuTAOTf (TA-
Au) yielded the allene intermediate isolated in excellent yield. This result suggested that TA-Au 
activated alkynes over allenes.5 
 
Figure 4: Chemoselectivity of TA-Au for alkyne activation over allene 
 
In another example, propargyl ethers were tested and similar chemoselectivity was 
observed for TA-Au as catalyst.6 
OAc
nBu OAcnBu
PPh3AuOTf
PPh3AuTAOTf
92%
0%98%
0%
•
nBu
OAc •
nBu
OAc
Au
! 4!
 
Figure 5: Propargyl vinyl ether 3,3 rearrangement by different gold catalysts 
 
Research objective 
 
One of the drawbacks to synthesis of propargyl ether has been the use of almost 
stoichiometric amount of mercury while the yield was not more than 60%. Mercury as a very 
toxic metal is not a good choice to perform reactions with.7 
 
Figure 6: Traditional synthesis of propargyl vinyl ethers 
 
We proposed to use propargyl alcohol and react it with an alkyne to generate a propargyl 
vinyl ether species in-situ. The resulting propargyl vinyl ether can then undergo a 3,3 
rearrangement (Saucy-Marbet rearrangement) to yield the allenone product, a very versatile 
molecule with a non-trivial synthesis. Moreover, propargyl alcohols are an easily synthesized 
starting material. 
O
nBu
PPh3AuOTf
PPh3AuTAOTf 0%93%
0%
•
nBu
O
O
OH
nBu
95%
•
nBu
O
Au
H2O
OH
nBu
+ O
Hg(OAc)2
O
nBu
! 5!
 
Figure 7: Proposed reaction between propargyl alcohol and alkyne !
Challenges 
 
One of the potential challenges of the proposed strategy has been the hydration side 
reaction of the propargyl alcohol. It was been reported that the hydration reaction occurs very 
fast and efficiently to furnish enones.8 
 
Figure 8: Gold-catalyzed hydration of propargyl alcohols 
 
Although, theoretically a water-free condition will prevent the unwanted hydration side 
reaction, it is very challenging to make the water-free propargyl alcohol. Besides, a molecule of 
water will generate in this hydration reaction which indicates that even a catalytic amount of 
water can drive the reaction to the undesired pathway. Alternatively, running the reaction in the 
glove box could solve the hydration problem, but the usefulness and practicability of this 
technically simplified synthetic methodology was attractive. 
 
The second challenge is regarding the chemoselectivity. It is known that allenones can 
undergo further cyclization to form pyran or indene. So, the choice of the catalyst could be very 
R3
[Au] O
R1 R2
OH
R1
R2
O
R1
R2
R3
+ O
R1
R2
R3 [Au]
H
R3
[Au]
•
R2
O
R3
R1
O
R1
R2
H Au
L
+
O H
H O
R2R1
OH
R1
R2
+ H2O
! 6!
tricky. 
 
Figure 9: Chemoselectivity challenge for allenone synthesis 
 
The desired catalyst would be able to activate terminal alkyne in the first step. In the 
second step the internal alkyne need to be activate. Finally, the catalyst should not be able to 
activate allene final product. 
Optimization of the reaction condition 
 
Table 1: Optimization of the reaction condition for allene synthesis 
!
 Cat. Sol. Time 
(h) 
Conv. 1a 
(%) 
4a 
(%) 
6a 
(%) 
5a 
(%) 
7a 
(%) 
1 PPh3AuNTf2 (5%) Toluene 12 66 0 7 28 65 
2 IPrAuNTf2 (5%) Toluene 12 67 0 6 18 65 
3 XPhosAuNTf2 (5%) Toluene 12 76 0 27 16 85 
4 (ArO)3PAuNTf2 (5%) Toluene 12 77 0 6 24 60 
5 [(Ph3PAu)3O]SbF6- (5%) Toluene 14 25 12 trace <5 <5 
6 [XPhosAu(MeCN)]+OTf- (5%) Toluene 14 70 25 20 25 25 
7 [XPhosAu(TA-H)]+OTf- (5%) Toluene 14 100 55 18 <5 <5 
8 [XPhosAu(TA-Me)]+OTf- (5%) Toluene 14 82 77 0 0 25 
9 [XPhosAu(TA-Me)]+OTf- (1%) Toluene (45oC) 8 100 94 0 0 22 
 
For the optimization of the reaction condition, compound 1a and phenylcetylene were 
R3OCH2C R
2
R1 = Ph
O
R1 R2
R3HO
R1 = alkyl
[Au] [Au]
•
R2
O
R3
R1
Ph
HO
n-Pr
1a
Ph
2a
(1.2 equiv)
•
Ph
O
Ph
n-Pr
[Au]
4a
O
Phn-Pr
5a
On-Bu Ph
Ph
6a
O
Ph
7a
rt
! 7!
chosen. PPh3AuCl and AgOTf did not give good conversion of the 1a. This could have been 
because of relatively fast decomposition of the naked gold in the presence of silver salts. Other 
gold cations failed to give good conversion of the 1a. Moreover a significant amount of enone 5a 
was formed in those cases. Switching the primary ligand to Xphos resulted in formation of 
allenone 4a. Switching the X ligand to acetonitrile, Echevarren catalyst, showed 25% of 4a 
formed. Finally, 94% of the desired allenone formed in the case of using XphosAu(TA-Me)OTf 
with 1.8 equivalent of 2a. 
Scope of the substrate !
This reaction has been very efficient for a wide range of propargyl alcohols and alkynes. 
For the propargyl alcohols, this reaction tolerated both aliphatic and electron deficient aromatic 
groups in R1, R2 and R3 positions. Both primary and secondary propargyl alcohols are 
successfully produces tri- and tetra-substituted allenes. Terminal propargyl alcohols (R1=H) were 
also suitable for this reaction with slightly lower yield (4v). In the case of electron donating 
aromatic group in R2 or R3, a diyne product was isolated with no allene obtained. Moreover, 
having a pyridine ring on the starting material resulted in almost no conversion of the starting 
material. This was likely due to strong bonding of the pyridine and gold which resulted in 
deactivation of the catalyst. 
For the scope of alkynes, both aliphatic and aromatic terminal alkynes showed 
competitive result for this reaction. Notably, more reactive conjugated alkynes also produced 4f 
and 4g in good yield. 
! 8!
Figure 10: Substrate scope of the allenone synthesis 
 
Chirality transfer from alcohol to allene 
 
After evaluating the substrate scope of the new transformation, we sought to evaluate the 
chirality transfer experiment to obtain chiral allenes. First we synthesized chiral compound 1a by 
1
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+ •
R1
O
R4
R3
4
[XPhosAu(TA-Me)]+TfO- (1%)
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! 9!
reducing the propargyl ketone by chiral a boron-hydride reagent. The reaction gave more than 
95% of chirality transfer since 96% enantiomeric excess of chiral 1a yielded 91% enantiomeric 
excess of 4a. We also tried kinetic resolution of the reaction of racemic propargyl alcohol, but 
not more than 30% ee of the allene observed using SegPhosAu(TA-Me)OTf. 
 
Figure 11: Chirality transfer experiment 
 
 
 
 
 
 
 !!
OH
n-Pr
Ph n-Pr
•
Ph
O Ph
(+)-1a
94% yield
+ Ph
2a
[XPhosAu(TA-Me)]+TfO- (1%)
toluene, 45 oC
(-)-4a
96% ee
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! 10!
 
 
PART II: GOLD/LEWIS ACID CATALYZED PROPARGYL ALCOHOL ADDITION 
TO ALKYNE TO YIELD FURANS 
 
Introduction 
 
Furan has been one of the important building blocks that exist in many natural products 
and drugs. Much effort has been done in synthetic chemistry to provide easy synthesis of furans. 
In gold catalysis, several reports exist that provide useful methods for furan synthesis.9 
        
Figure 12: Gold-catalyzed method for furan synthesis 
 
During the synthesis of allenes in the first part of this thesis, we observed formation of 
furan by-product in some cases. So, we sought to evaluate the furan formation reaction through a 
tandem reaction of propargyl alcohols and alkynes. 
 
•
R"R
X
O
R' 2% AuCl3
up to 3 days
O R
XR'
R"
R"
R
O
R'
+ 1% PPh3AuOTf
O R"R
MeOH
Me
R
O
Me COOEt 2% PPh3AuCl2% AgOTf O Me
Me COOEt
R
MeO
R'
! 11!
Pyran versus furan formation 
 
During our screening the reaction for allene synthesis, we observed that in certain cases 
the furan formed as minor product. This result encouraged us to develop a new method for furan 
synthesis since furans are important heterocycles in chemical research. The question that rose 
was the two different reaction pathways for allenone cyclization. The allenone can undergo 5-
exo and 6-endo cyclizations. The 6-endo pathway was well-known whereas the 5-exo path has 
not been prevalent. The possible reason for dominant 6-endo pathway, which yields pyrans, was 
the formation of relatively stable vinyl-gold intermediate. On the other hand, 5-exo pathway, 
which yielded a furan, would result in unstable Csp3-Au bond. Notably, allenones that yielded 
pyran were only allene-aldehydes. 
To understand the basis of this allenone cyclization we performed several reactions with 
allene-aldehyde and allene-ketone substrates. 
 
Figure 13: Furan or pyran formation 
 
Treating allene-aldehyde 8a with PPh3AuNTf2 in dry toluene resulted in a complex 
reaction mixture. Performing the same reaction in methanol yielded 9 in 95%. On the other hand, 
reacting allene-ketone 8b with PPh3AuNTf2 in dry toluene formed the furan 10 in 80%. 
Performing the same reaction of 8b in methanol yielded both pyran and furan in almost 1:1 
mixture. 
•
O
n-Pr Ph
O
O
R
n-Bu
Phn-Pr Ph
+
R
8a: R = H; 8b: R = Ph
[Au] cat. MeO R
9 10
! 12!
Therefore, we suggested that the 6-endo cyclization was the favoured path because of the 
formation of more stable vinyl-gold intermediate.  However, protodeauration of a stable vinyl-
gold intermediate was relatively slow. The allenone was in equilibrium with its enol tautomer, 
which can adopt either E or Z geometries. 
 
Figure 14: Plausible cyclization mechanism of allenones 
 
The 5-exo cyclization required the formation of Z-enol, which then can produced furan 
after protodeauration. On the other hand, with allene-aldehyde, the trans isomer (E-enol) will be 
dominant, which cannot undergo the next cyclization. 
Optimization of the reaction condition 
 
For the screening of the reaction condition, we found out that using copper Lewis acid 
was necessary for the reaction. Without using any Lewis acid the TA-Au was not able to activate 
the allene effectively. 
Upon addition of copper, the chemoselectivity of the TA-Au will diminish significantly; 
so, the gold catalyst could have activated the allene. Our recent kinetic study of the propargyl 
acetate migration suggested that the Lewis acid could help TA ligand to be dissociated from the 
•n-Pr Ph
R
O [Au] O
Ph
R
n-Pr
[Au]
+
stable vinyl gold
6-endo
•n-Pr Ph
R
HO [Au]
5-exo
O
Ph
n-Pr
R
[Au]
•n-Pr Ph
OH
R
vs
E-isomer Z-isomer
R = H
perferred
H+
- [Au]+
MeOH
slow
- [Au]+
O
n-Pr
OMe
R
Ph
no rxn
O
Ph
n-Bu RR ≠ H
! 13!
gold catalyst. Noticeably, TA decoordination from the gold was the turnover-limiting step of the 
reaction. !!
Table 2: Optimization of the reaction condition for furan synthesis 
 
 Cat. Sol. Time 
(h) 
Conv. 1a 
(%) 
8a 
(%) 
10a 
(%) 
5a 
(%) 
7a 
(%) 
1 [(Ph3PAu)3O]SbF6- (5%) Toluene 14 25 12 trace <5 <5 
2 [XPhosAu(MeCN)]+OTf- (5%) Toluene 14 70 25 20 25 25 
3 [XPhosAu(TA-H)]+OTf- (5%) Toluene 14 100 55 18 <5 <5 
4 [XPhosAu(TA-Me)]+OTf- (5%) Toluene 14 82 77 0 0 25 
5 [XPhosAu(TA-H)]+OTf- (1%) 
Cu(OTf)2 (0.05%) 
Toluene (45oC) 8 100 8 80 0 27 
 
Upon addition of copper, the chemoselectivity of the TA-Au will diminish significantly; 
so, the gold catalyst could have activated the allene. 
Our recent kinetic study of the propargyl acetate migration suggested that the Lewis acid 
could help TA ligand to be dissociated from the gold catalyst. Noticeably, TA decoordination 
from the gold was the turnover-limiting step of the reaction. 
Substrate scope 
 
This new methodology worked very well for the synthesis of variety of furan 
heterocycles. For the alkyne scope, both aliphatic and aromatic alkynes were suitable for this 
reaction. Both electron-deficient and electron-rich aromatic rings were successful. Also, both 
strictly hindered and non-hindered aliphatic alkynes worked very well. 
Ph
HO
n-Pr
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Ph
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(1.2 equiv)
•
Ph
O
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[Au]
8a
O
Phn-Pr
5a
On-Bu Ph
Ph
10a
O
Ph
7a
rt
! 14!
 
Figure 15: Substrate scope of the furan synthesis 
 
For the propargyl alcohols, both primary and secondary alcohols were suitable for this 
reaction. Aromatic groups at R2 position are good for the reaction whereas aromatic group at R1 
did not yield furan product due to fast propargyl alcohol dimerization. 
Propargyl vinyl ether isomerization 
 
In the case of using benzylalkyne, a different product was observed. The tetra-substituted 
furan 10r was identified as the product. The key part of the mechanism of this new 
transformation was assumed to be the vinyl ether isomerization. After the formation of the 
propargyl vinyl ether, it could isomerize to more stable conjugated double bond.  The consequent 
3,3 rearrangement would yield the allene and finally the tetra-substituted furan. 
On-Bu
Ph
10a, 80%
On-Bu
n-Bu
Ph
10c, 83%
On-Bu
Cy
Ph
10d, 73%
On-Bu
3-Cl-C6H5
Ph
10b, 78%
Ph
On-Bu
Ph
10e, 72%
On-Bu
n-Bu
10f, 98%
On-Bu
n-Bu
10i, 77%
On-Bu
3-Cl-C6H5
n-Bu
10h, 89%
On-Bu
3-F-C6H5
n-Bu
10g, 95%
Ph S
O
Ph
10l, 83%
Ph
O
Ph
10n, 80%
Cy
O
Ph
10m, 78%
S
On-Hept
10p, 56%
Ph
On-Bu
n-Bu
10r, 97%
On-Bu
Ph
10t, 90%
Ph Ph
t-Bu
On-Bu
n-Bu
n-Bu
10j, 96%
On-Bu
n-Bu
Cy
O
Ph
10o, 71%
Cl
3
On-Bu
10q, 50%
Ph
O
Ph
Ph
10s, 83%
10k, 93%
1
R3
2
+
TA-Au (1%)
Cu(OTf)2, (0.5%)
OH
R1
R2
O
R3
R2 10
R1
Toluene, 45 oC
! 15!
 
Figure 16: Plausible mechanism for tetra-substituted furan formation 
 
Expansion to Hashmi phenol synthesis !
Hashmi phenol synthesis has been a well-developed method to synthesis phenols from 
furyl-ynes.10 His group investigated this reaction in detail and they were able to achieve different 
functionalized phenols in excellent yield. 
Our achievement in furan synthesis led us to speculate the use our system in the synthesis 
of more functionalized furans to get more functionalized phenols. Hashmi’s phenol reaction had 
some limitations that limit the substrate scope of the phenol formation drastically. The big 
limitation of this reaction was that R group on the furan has to be hydrogen, methyl group or 
aromatic ring. 
 
Figure 17: Gold-catalyzed furyl-yne reaction 
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Plan !
Using our method to synthesize furans, we were able to synthesize different kinds of 
furyl-ynes and study this phenol synthesis thoroughly. The furyl-yne starting material designed 
to synthesize by a propargyl alcohol and a diyne. One of the alkynes in diyne was protected with 
TIPS. So, the propargyl alcohol could react with the non-protected terminal alkyne. The resulting 
furan was then synthesized using our method. However, lower yield was observed due to steric 
hindrance and decomposition of the diyne substrate. Then, the TIPS was deprotected and the 
final gold-catalyze step performed. (PhO)3PAu(TA-Ph)OTf was used to catalyze the reaction. 
Analyzing the product of the reaction revealed that no phenol or vinyl-furan formed. 
Interestingly, a spiro product formed instead, which inspired us to discover the mechanism of 
this new reaction. 
 
Figure 18: To mimic Hashmi phenol synthesis reaction 
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Comparing the Hashmi’s substrate with our case indicated that there are some differences 
that could have been the reason for the different reaction path. In the Hashmi’s cases the C2 
position of the furan has only H, CH3 or aromatic rings. Moreover, C3 had to be H to offer 
acceptable yield. In our substrate, we had butyl groups on C2 and C3 position. Therefore, we 
postulated that the steric effect of the alkyl group at C3 position might have been the reason for 
different reactivity that somehow preferred fast protodeauration. 
 
 
Figure 19: Details of phenol versus spiro synthesis of furyl-ynes 
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PART III: GOLD/LEWIS ACID CATALYZED HOMOPROPARGYL ALCOHOL 
ADDITION TO ALKYNE  !
Background !
One of the well-investigated reactions transition metal catalysis has been enyne 
cycloisomerization. Different metals have been used for reaction discovery using enynes 
including: iron, rhodium, gold and so on. In gold catalysis, depends on exo versus endo 
selectivity in cyclization, different products have been achieved. The mechanism of enyne 
cycloisomerization always revealed valuable insights for chemists. Moreover, precious products 
can be achieved by enyne cycloisomerizations. Enyne cycloisomerizations are also used in 
natural product synthesis.11 
 
Figure 20: Enyne cycloisomerizations 
 
Our achievements in intermolecular propargyl alcohol addition to alkynes motivated us to 
investigate intermolecular homo propargyl alcohol addition to alkynes. The product would be a 
1,6-enyne that can undergo cycloisomerizations.12 Interestingly, among all the studied enynes, 
this kind of enyne has not been studied yet. 
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Figure 21: Different enynes employed for cycloisomerization 
 
Potential challenge !
One of the biggest obstacles in the gold catalyzed homo propargyl alcohol reactions was 
the formation of dihydrofuran. This suggest that the catalyst needed to be selective enough to 
prevent intramolecular internal alkyne activation. 
   
Figure 22: cyclization of homo propargyl alcohols 
 
Testifying the hypothesis !!
The investigation began with reaction of homopropargyl alcohol 16 with 1-hexyne and 
XPhosAu(TA-H)OTf catalysts. Interestingly, dihydrooxepine was identified as major product 
whereas the bicyclic product was not observed. 
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Figure 23: Oxepine formation mechanism 
 
The reason could have been the more thermodynamic stability of the intermediate leading 
to dihydrooxepine. As shown on the next figure, the oxonium cation might have been more 
stable than the positive charge on the gold-carbene. 
Optimization of the reaction condition !
Cationic gold complexes resulted in formation of dihydrofuran and homo propargyl 
alcohol addition to dihydrofuran, which could be a gold and proton-catalyzed reaction. 
Employing triazole as secondary ligand significantly reduced byproduct formations. And a 
combination of 5% XPhosAu(TA)OTf and 1% Cu(OTf)2 yielded dihydrooxepine in 84% yield. 
Although the oxepine formed in good yield identified by HNMR, the isolation of it was 
problematic due to decomposition. Examining different column chromatography conditions also 
did not help to isolate oxepine. Therefore we decided to use dihydrooxepine as an electron rich 
diene to do a Diels-Alder reaction. 
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Table 3. Optimization of the reaction condition for oxapine synthesis 
   
 Cat. Time 
(h) 
Conv. 
(%) 
17a + 18a’ 
(5%) 
19a 
(%) 
1 PPh3AuNTf2 (5%) 10 56 46 0 
2 XPhosAuNTf2 (5%) 15 90 40 33 
3 XPhosAu(TA-H)OTf (5%) 30 72 16 37 
4 XPhosAu(TA-H)OTf (5%) / Cu(OTf)2 (1%) 24 100 11 84 
5 XPhosAuNTf2 (5%) / Cu(OTf)2 (1%) 24 100 60 32 
 
Addition of maleic anhydride to the solution of the first reaction helped to isolate the 
Diels-Alder product in excellent yield. 
 
Figure 24: One pot reaction toward oxapine synthesis and utilization 
 
Notably, excellent stereoselectivity was observed in the Diels-Alder reaction with only 
one isomer isolated. 
Substrate scope !
The scope of the reaction was limited to the use of aliphatic alkynes only. The aromatic 
alkynes resulted in a complex reaction mixture. 
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Figure 25: Scope of the substrates of compound 21 
 
Another limitation of this substrate scope was the necessity of use of aromatic ring on R2 
position. This was likely because of the different cyclization pathways, 7-endo versus 6-exo. For 
the scope of the dienophiles, maleic anhydride, N-methyl malenamide and tetracyanoethylene 
were successful to yield the desired product. Notably, in all of the cases, only endo product was 
observed. 
1,3-Alkoxyl shift !
In the case of substrate 8e, when using cyclopropylacetylene, another product formed. 
NMR analysis and obtaining crystal structure demonstrated that a 1,3-alkoxy shift took place to 
form compound 22e. 
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Figure 26: 1,3-Alkoxyl shift 
 
Later we discovered that all the compounds 21 can undergo 1,3-alkoxyl shift in higher 
temperature. 
Substrate scope !
 
Figure 27: Substrate scope of compound 22 
Hydrobenzofuran substrates were prepared according to the standard condition in 70 oC. 
This cascade reaction provided only one isomer as product. The limitation of this 1,3-alkoxy-
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shift reaction was when using tetracyanoethylene. Tetracyanoethylene substrates 21 were 
extremely stable even after heating at 100 oC for two days. !
Chirality transfer !
Employing chiral homo propargyl alcohol resulted in formation of enantiomerically pure 
final product. Therefore this methodology was able to set up five stereogenic centers in one 
reaction. The chirality transfer was near quantitative. 
      
Figure 28: Chirality transfer experiment !
Plausible mechanism !
The mechanism of this rearrangement could be either stepwise or concerted. If it was a 
stepwise mechanism, the C-O bond dissociation would seem to be the first step of this 
transformation. Then, it can undergo double bond migration and final ring closing. However, the 
cyclopropane ring expansion was supposed to happen, while we had not observed any other side 
product in this rearrangement. These observations favored a concerted mechanism as the 
plausible mechanism. 
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Figure 29: Plausible mechanism of 1,3-alkoxyl shift !
Investigation of the side product !
During these reactions a minor side product was isolated (~5%) when using 1-hexyne. 
Efforts to determine the structure of this mysterious side product were carried out by HNMR and 
confirmed by X-ray crystallography. 
 
Figure 30: Minor products isolated 
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Surprisingly, the butyl group seemed to be migrating in an unknown way. To determine 
the mechanism of this reaction, we performed several experiments. 
First of all, we charged compound 21 with Au, Cu, heat and other various conditions. 
However, in all of the cases no compound 23 formed. Charging compound 22 with various 
conditions also did not form any of compound 23. These pieces of evidences led us to believe 
that formation of 23 was taking place from the very first step where homo propargyl alcohol 16 
and alkyne 17 react. 
 
Figure 31: Investigation of the minor product formation 
 
Finally, a mechanism was proposed that indicates formation of dihydrofuran as the key 
intermediate in this transformation. In the next step, the dihydrofuran as nucleophile attacks to 
alkyne activated by gold followed by protodeauration to yield a diene. The double bond 
migration forms more stable alkene. Finally, s-trans to s-cis conformational change can make a 
suitable diene for Diels-Alder reaction. 
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Figure 32: Proposed mechanism of the minor product formation !!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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PART IV: TIAZOLE-GOLD CATALYZED HYDROALKYNYLATION OF VINYL 
ETHERS 
 
Introduction !
Enyne cycloisomerization has been one of the developed reactions in gold catalysis. 
Intramolecular reaction of enynes showed to yield different cyclized products. Intermolecular 
reaction of alkyne and alkenes proved to furnish a cyclobutene product upon the stepwise 2+2 
reaction. This reactions vastly investigated by Echevarren’s research group. He employed these 
2+2 reactions to form natural products and macrocyclizations. Most of the time he used aromatic 
alkenes for this reactions.13 
    
Figure 33: Gold-catalyzed intermolecular reaction of alkyne and alkene 
 
We wonder why vinyl ethers have not been employed as an alkene source in this 
transformation yet. One reason was the activation of vinyl ether by gold rather than alkyne 
activation, which may result in stable complex or most of the times vinyl ether polymerization. 
Employing a less reactive gold catalyst could have been a solution to reduce interaction of vinyl 
ethers and gold catalyst. Performing a reaction of dihydropyran 24a as standard vinyl ether with 
phenylacetylene under gold conditions resulted in alkynylation of vinyl ether as a new 
R2
R1
R3
R1
R2 R3R2
R1
R3
[Au][Au]
R1
R2 R3
[Au]
! 29!
unprecedented product. Testing the reaction, both PPh3AuNTf2 and [PPh3Au(TA-H)]OTf (TA-
Au) formed only alkynylation product with no 2+2 product observed. Notably, TA-Au showed 
better yield of the product, which was in agreement with our hypothesis that too reactive 
PPh3AuNTf2 caused oligomerization and polymerization of vinyl ether starting material. 
 
     
Figure 34: Investigation of the gold-catalyzed vinyl ether reaction with alkyne 
 
Screening the reaction condition 
 
Screening different catalysts revealed that a phosphite primary ligand on gold was the 
best for this reaction in which formation of gold-acetalyde was to be facilitated.  
Table 4: Optimization of the reaction condition for alkynylation reaction 
 
 Cat. Time (h) Conv. (%) 27 (%) 
1 PPh3AuNTf2 (3%) 2 100 24 
2 IPrAuNTf2 (3%) 2 100 <10 
3 XPhosAuNTf2 (3%) 2 100 16
 
4 (ArO)3PAuNTf2  (3%) 2 100 44
 
5 (ArO)3PAu(TA-H)OTf  (3%)
 
4 100 54
 
6 (ArO)3PAu(TA-H)OTf  (3%)
 
4 100 56
 
7 (ArO)3PAu(TA-H)OTf  (3%) 
(1a was added slowly over 3 h)
 4 100 78
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Moreover, slow addition of vinyl ether was important to prevent oligomerization and 
polymerization. 
Substrate scope 
 
This alkynylation product had excellent substrate tolerability since it was suitable for all 
kinds of alkynes. All aromatic and aliphatic alkynes yielded the desired product in high yields. 
Scope of vinyl ethers showed that di, tri-substituted vinyl ethers work in this condition. Whereas 
mono-substituted vinyl ethers were too reactive and tetra-substituted vinyl ethers were too stable 
to yield the desired product in acceptable yields. 
Figure 35: Substrate scope          
  !
Ferrier-type rearrangement. 
 
Glycals are a type of sugar derivatives that posses a vinyl ether moiety. Examining the 
glycal starting material did not give the simple alkynylation product. Analyzing the isolated 
product proved that an acetate group is loosing during the reaction to yield compound 29a. The 
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mechanism of this reaction was expected to go through the Ferrier rearrangement catalyzed by 
gold.14 
 
Figure 36: Plausible mechanism of the gold-catalyzed Ferrier-type reaction !
Substrate scope 
 
 The scope of the substrates revealed that the type of the protecting group did not harm 
this reaction. All OAc, OBz, OBn and OTBS protecting groups yielded the same alykylation 
product. The ratio between alpha and beta isomers was the only difference in using different 
protecting groups.  Having no OPG in 6 position did not effect the reaction product either. 
 Aromatic alkynes were suitable for this reaction, whereas aliphatic alkynes yielded 
significantly less amount of the product, which were also difficult to isolate. 
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Figure 37: Substrate scope 
 
Mechanistic evaluation 
 
 We proposed that gold-acetalyde intermediate as a key catalytic species for this reaction. 
Several reactions were performed to get a sense of the mechanism of this reaction. A control 
reaction with HOTf did not furnish any product. This rules out that in-situ generated HOTf is 
able to catalyze this reaction. To prove that gold-acetalyde was the active catalyst, we 
synthesized compound E. Stoichiometric amount of E did not form product, which demonstrated 
that it was not able to activate vinyl ether. However, addition of HOTf to the reaction could 
result in the product formation. This information suggests that the catalytic amount of HOTf that 
forms from the reaction of alkyne and gold to form gold-acetalyde was necessary to activate the 
vinyl ether. Then gold-acetalyde is able to deliver the acetalyde to the oxonium cation. 
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Figure 38: Mechanistic investigation of alkynylation reaction 
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PART V: CYCLOPROPANOL RING OPENING BY GOLD-REDOX CATALYSIS  !
Introduction !
 Gold redox chemistry has attracted a lot of attention recently. Formation challenging C-C 
and C-heteroatom bonds were investigated in this chemistry pioneered by Hashmi, Toste and 
Zhang. In all the cases, the formation of Gold-Carbon bond was the key step where next it can 
undergo reductive elimination to afford the new C-C or C-X bonds. These strategies provided a 
unique method for functionalizing alkenes, alkynes and allenes. As shown in the next figure, the 
nucleophile attacks to the C-C multiple bond which was activated by the gold catalyst. As a 
result, a carbon-gold bond was formed.15 Although this was very attractive since it enables 
functionalizing C-C multiple bonds, the scope of the substrates for gold catalysis was limited to 
the compounds containing C-C multiple bond. Moreover, mechanistic ambiguity of these 
processes, encouraged us to design a system that could resolve these issues and partially answer 
some questions about the mechanisms. 
  
Figure 39: Divers methods of formation of Au-C bond 
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Research objectives !
 We proposed that cyclopropanols could potentially undergo ring opening as highly 
strained rings, which will result in formation of a new C-Au bond. If this hypothesis works, the 
applicability of the gold catalysis reaction will improve, because there will be no need to C-C 
multiple bond to form C-Au bond.  After reductive elimination, the beta-substituted ketone will 
be the product that has synthetic applicability. 
 
 
Figure 40: Proposed reaction for formation of Au-C bond !
 During the past several years our group developed base-assisted diazonium activations to 
oxidize Au(I) to Au(III) to form various coupling products. To initiate this project, we needed to 
answer a crucial question that whether gold catalysts can open cyclopropanol rings or not. To 
testify our hypothesis, we synthesized cyclopropanol 31a by Kulinkuvich reaction and subject it 
to several catalytic reactions. Notably, synthesizing cyclopropanols are very easy one step 
synthesis which enhances the attractiveness of our proposed strategy. 
 
 
Figure 41: Testifying the hypothesis         
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 PPh3AuCl did not show any conversion of the starting material whereas cationic gold 
PPh3AuNTf2 and gold(III) opened the cyclopropanol ring in very high efficiency. Finally the 
protodeauration formed the desired ketone in high yield. 
Screening of the reaction condition !
 Encouraged with these initial results, we began screening the reaction condition. As 
shown in the next Table, no conversion of 31a was observed without gold (entry 1), which 
confirmed the crucial role of the gold catalyst for this transformation. Also, without base the 
reaction only gave 32a (entry2). Using PPh3AuCl and sodium bicarbonate as base, product 33a 
was yielded, although the major product was the product 32a (entry 3). Screening the base in this 
reaction revealed lithium carbonate as the best for this reaction. 
Table 5: Screening of the reaction condition for cyclopropanol ring opening.   
  
 Cat. Additive 
 
Conv. 
(%) 
32a 
(%) 
33a 
(%) 
1 - NaHCO3  (2eq) <5 0 0 
2 10% PPh3AuCl - 100 93 0 
3 10% PPh3AuCl NaHCO3  (2eq) 87 43 36 
4 10% PPh3AuCl Li2CO3 (2eq) 95 5 68 
5 10% PPh3AuNTf2 Li2CO3 (2eq) 100 55 27 
6 10% (p-CF3C6H4)3PAuCl Li2CO3 (2eq) 90 10 38 
7 10% (o-tol)3PAuCl Li2CO3 (2eq) 96 5 75 
8 10% (p-tol)3PAuCl Li2CO3 (10eq) 96 trace 77 
  
 Screening the gold catalyst revealed that cationic gold PPh3AuNTf2 form 55% of the 
undesired hydration product (entry 5). Screening the primary ligand on gold showed that electron 
deficient phosphine ligand gave lower conversion (entry 6). Bulky ligand (o-tol)3P also gave 
lower conversion of 31a (entry 7). Finally, (p-tol)3PAuCl as catalyst with 10 equivalent of 
lithium carbonate yielded 33a in 77%. 
OHp-Tol p-Tol
OCat.
CH3CN, 50 oC, 6h
H
31a 32a
p-Tol
O Ar
33a
+2 eq ArN2BF4
Ar = 4-F-C6H4
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Substrate scope !
 With the best condition in hand, we started screening the scope of the substrates. As 
shown in the substrate scope table, this nucleophilic activation method worked well for a wide 
range of aryl diazonium salts and cyclopropanols. 
        
Figure 42: Substrate scope of the reaction 
  
 Consistent with other reported methods for gold redox catalysis, only electron deficient 
aryl diazonium salts work for this reaction (33a-33d). Diazoniums with no substituent and with 
electron donating substituents failed to yield any product. 
 For the scope of cyclopropanols, this reaction worked well for the both electron rich and 
electron deficient benzyl groups in R1 position (33a-33i). Having an aryl groups in R1 position 
gave the best yields for this reaction perhaps because of more active cyclopropanol ring (33j-
33m). Both electron deficient and electron rich aryl group in R1 also work very well. For the case 
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of having substituents on the cyclopropane ring, the less hindered side tend to for C-Au bond 
followed by reductive elimination (33o). 
 Surprisingly, for the case of 33n, a much lower yield was observed. A diazone side 
product was observed in 35%. While for the case of 33a, no diazone compound observed. This 
suggested that the steric effect of the methyl group on the ortho position switched the reaction 
pathway. With this idea, we designed to synthesize tert-butyl group adjacent to the 
cyclopropanol. The result demonstrated that the corresponding diazone compound formed as 
major product. 
 
Figure 43: Reasoning for different reactivity 
 
 Still questionable in diazonium gold oxidation was the oxidation of gold(I) to gold(III) 
going through a radical or two-electron process. To answer this critical question, we synthesized 
a cyclopropanol with cyclopropane as an adjacent group. In this case, also the diazone product 
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formed as major product with no cyclopropane ring opening observed. Moreover, the control 
experiment suggested that this reaction was catalyzed by gold. 
 To expand the substrate scope, we then synthesized a cyclobutanol and subject it to the 
reaction conditions but no conversion was observed. It suggested that the π-character of the 
cyclopropane ring is essential to be activated by the gold catalyst. 
Utilizing all of this information about the transformation, we proposed the following mechanism 
to explain these observations. 
Figure 44: Proposed mechanism 
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GENERAL SUPPORTING INFORMATION !
Unless noted, all reagents and solvents were obtained from commercial providers and 
used without further purification. 1H and 13CNMR data was recorded on an Agilent 400 NMR 
spectrometer. Chemical shifts for starting materials and products were recorded relative to 
internal TMS (0.00 ppm) for 1HNMR and CDCl3 (77.0 ppm) for 13CNMR data. Column 
chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with pre- coated, glass-baked plates (250µ) and visualized by 
fluorescence or charring with potassium permanganate stain. HRMS were recorded on LTQ-
FTUHRA spectrometer. 
Supporting information for allene synthesis  !
General procedure for allene synthesis !
 
Figure 45. General reaction for allene synthesis !
To a vial, 0.7 ml of toluene added  and charged with 0.5 mmol of propargyl alcohol 
followed by the addition of 0.9 mmol of alkyne and then 0.005 mmol of the XphosAu(TA-
Me)OTf in ambient temperature. The mixture stirred at 45 oC and tracked by TLC until complete 
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consumption of 1a. The reaction mixture was then directly loaded on column chromatography on 
silica gel for separation by hexane/ethyl acetate to obtain the desired product. 
Synthesis of XPhosAu(TA)OTf  
A vial was charged with XPhosAuCl (355 mg, 0.5 mmol) and benzotriazole (1.1 equiv.) 
in dry DCM (10 mL). After everything dissolved, the AgOTf (1.05 equiv.) added to the solution. 
The vial was stirred at room temperature for four hours. The reaction mixture was filtered 
through three celite pads followed by concentration in vacuum to yield a foam-like solid. Pure 
XPhosAu(TA)OTf catalyst was obtained by recrystallization of the crude product through 
diffusion of hexanes into DCM solution. 
Chirality transfer experiment for allene synthesis !
 
Figure 46. General reaction for chirality transfer experiment to allene !
Enantiomeric excess of allene was determined by HPLC with chiralcel OD column; λ = 
260 nm; eluent: Hexane/Isopropanol = 95/5; Flow rate: 1ml/min; t = 7.66 min, t = 11.24 min, 
91% ee. 
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Characterization data for allene synthesis 
 
 
1HNMR (400 MHz; CDCl3): δ 8.00-7.97 (m, 2H), 7.57-7.53 (m, 1H), 7.46-7.38 (m, 4H), 7.33-
7.29 (m, 2H), 7.22-7.20 (m, 1H), 5.46 (m, 1H), 4.03 (dd, J1= 15.1 Hz, J2= 2.8 Hz 1H), 4.06 (dd, 
J1= 15.1 Hz, J2= 2.8 Hz 1H), 1.93-1.87 (m, 2H), 1.33 (q, J = 7.4 Hz, 2H), 0.87-0.83 (t, J = 7.2 
Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 205.2, 197.7, 136.5, 136.2, 133.0, 128.7, 128.46, 128.42, 126.73, 
125.68, 100.4, 95.4, 41.2, 30.6, 22.3, 13.7 
HRMS calculated for C20H21O [M+H]+: 277.1586, Found: 277.1586 
 
1HNMR (400 MHz; CDCl3): δ 7.96 (t, J = 1.9 Hz, 1H), 7.86-7.83 (m, 1H), 7.53-7.50 (m, 1H), 
7.40-7.36 (m, 3H), 7.34-7.30 (m, 2H), 7.22 (m, 1H), 5.48 (m, 1H), 4.00 (dd, J1= 14.9 Hz, J2= 2.4 
Hz 1H), 4.02 (dd, J1= 14.9 Hz, J2= 2.4 Hz 1H), 1.93 (q, J = 7.3 Hz, 2H), 1.35 (m, 2H), 0.87 (t, J 
= 7.4 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 205.1, 196.4, 138.0, 135.9, 134.8, 132.9, 129.8, 128.7, 128.5, 
126.85, 126.75, 125.6, 100.2, 95.6, 41.4, 30.5, 22.3, 13.7 
nPr
O
nPr
O
Cl
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HRMS calculated for C20H20ClO [M+H]+: 311.1197, Found: 311.1198 
 
1HNMR (400 MHz; CDCl3): δ 7.36-7.28 (m, 4H), 7.21-7.19 (m, 1H), 5.59 (m, 1H), 3.47 (d, J = 
2.2 Hz, 2H), 2.51 (t, J = 7.4 Hz, 2H), 2.16-2.11 (m, 2H), 1.56-1.50 (m, 4H), 1.28 (m, 2H), 1.01-
0.94 (m, 3H), 0.87 (t, J = 7.3 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 208.9, 205.0, 135.8, 128.1, 126.4, 125.4, 99.6, 94.1, 45.6, 40.8, 
30.5, 25.5, 22.13, 21.94, 13.48, 13.45 
HRMS calculated for C18H25O [M+H]+: Exact Mass: 257.1900, Found: 257.1907 
 
1HNMR (400 MHz; CDCl3): δ 7.33-7.25 (m, 4H), 7.17 (s, 1H), 5.56 (s, 1H), 3.51 (d, J= 2 Hz, 
2H), 2.58 (s, 1H), 2.12 (q, J = 7.3 Hz, 2H), 1.83-1.75 (m, 5H), 1.52 (m, 2H), 1.35 (m, 2H), 1.25-
1.19 (m, 3H), 0.97 (t, J = 7.3 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 211.8, 205.3, 136.3, 128.4, 126.6, 125.7, 99.9, 94.3, 49.2, 44.0, 
30.9, 28.6, 25.81, 25.67, 22.5, 13.8 
HRMS calculated for C20H27O [M+H]+: 283.2056, Found: 283.2054 
nPr
nBu
O
nPr
O
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1HNMR (400 MHz; CDCl3): δ 7.35-7.29 (m, 4H), 7.21-7.18 (m, 1H), 5.61 (tt, J = 4.5, 2.2 Hz, 
1H), 3.51(d, J= 6.4 Hz, t), 3.49 (d, J= 2.4 Hz, 2H), 2.71 (t, J = 7.0 Hz, 2H), 2.14-2.13 (m, 2H), 
2.04-1.99 (m, 2H), 1.55-1.49 (m, 2H), 0.97 (t, J = 7.4 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 207.8, 205.3, 135.9, 128.5, 126.8, 125.6, 99.7, 94.6, 46.0, 44.4, 
38.0, 30.8, 26.3, 22.4, 13.8 
HRMS calculated for C17H22ClO [M+H]+: 277.1354, Found: 277.1363 
 
1HNMR (400 MHz; CDCl3): δ 7.36-7.34 (m, 2H), 7.28 (m, 2H), 7.17 (m, 1H), 6.96 (m, 1H), 5.50 
(m, 1H), 3.71 (dd, J1= 16.2 Hz, J2= 2.4 Hz 1H), 3.74 (dd, J1= 15.1 Hz, J2= 2.8 Hz 1H) (m, 2H), 
2.26-2.21 (m, 4H), 2.07-2.02 (m, 2H), 1.64-1.59 (m, 4H), 1.46 (m, 2H), 0.93 (t, J = 9.7, 5.0 Hz, 
3H). 
13CNMR (100 MHz; CDCl3): δ 205.0, 198.7, 140.7, 138.8, 136.5, 128.3, 126.6, 125.7, 101.2, 
94.9, 39.9, 30.9, 26.2, 23.2, 22.5, 22.0, 21.6, 13.9 
HRMS calculated for C20H25O [M+H]+: 281.1900, Found: 281.1908 
nPr
O
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1HNMR (400 MHz; CDCl3): δ 7.33-7.26 (m, 4H), 7.17-7.13 (m, 1H), 6.01 (d, 1H), 5.79 (m, 1H), 
5.51-5.48 (m, 1H), 3.77 (dd, J = 2.6, 1.3 Hz, 2H), 2.04 (m, 2H), 1.85 (dd, J = 1.4, 0.9 Hz, 3H), 
1.45 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 205.0, 199.4, 144.1, 136.3, 128.3, 126.6, 125.7, 125.3, 100.7, 
95.0, 40.3, 30.8, 22.4, 17.7, 13.8 
HRMS calculated for C17H21O [M+H]+: 241.1587 Found: 241.1594 
 
1HNMR (400 MHz; CDCl3): δ 7.36 (m, 2H), 7.32-7.28 (m, 2H), 7.19 (m, 1H), 5.59 (m, 1H), 3.59 
(d, J = 2.2 Hz, 2H), 2.16-2.10 (m, 3H), 1.52 (q, J = 7.4 Hz, 2H), 1.02-1.00 (m, 2H), 0.96 (t, J = 
7.4 Hz, 3H), 0.84-0.81 (m, 2H). 
13CNMR (100 MHz; CDCl3): δ 208.7, 205.5, 136.3, 128.4, 126.7, 125.7, 99.8, 94.5, 46.5, 30.9, 
22.4, 19.5, 13.8, 11.4 
HRMS calculated for C17H21O [M+H]+: 241.1587, Found: 241.1587 
 
nPr
O
nPr
O
nBu
O
nPr
! 46!
1HNMR (400 MHz; CDCl3): δ 7.99-7.97 (m, 2H), 7.56-7.54 (m, 1H), 7.45 (t, J = 7.8 Hz, 2H), 
5.08 (m, 1H), 3.56 (d, J = 2.5 Hz, 2H), 2.03 (td, J = 7.4, 3.0 Hz, 2H), 1.83 (q, J = 7.3 Hz, 2H), 
1.45-1.39 (m, 2H), 1.31 (m, 4H), 0.90 (t, J = 7.2 Hz, 3H), 0.86 (t, J = 7.4 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 202.9, 198.4, 136.8, 133.1, 128.9, 128.6, 99.1, 92.8, 44.0, 32.4, 
31.2, 29.9, 22.63, 22.49, 14.2, 13.9 
HRMS calculated for C18H25O [M+H]+: 257.1900, Found: 257.1908 
 
1HNMR (400 MHz; CDCl3): δ 7.94 (t, J = 1.8 Hz, 1H), 7.85-7.83 (m, 1H), 7.51 (ddd, J = 8.0, 
2.1, 1.1 Hz, 1H), 7.38 (t, J = 7.9 Hz, 1H), 5.09 (s, 1H), 3.54 (d, J = 2.5 Hz, 2H), 2.00 (td, J = 7.4, 
3.1 Hz, 2H), 1.83 (dd, J = 14.7, 6.8 Hz, 2H), 1.45-1.37 (m, 2H), 1.35-1.24 (m, 4H), 0.90-0.83 (m, 
6H). 
13CNMR (100 MHz; CDCl3): δ 202.7, 196.8, 138.1, 134.7, 132.8, 129.7, 128.9, 126.8, 98.6, 
92.9, 43.9, 32.2, 30.9, 29.6, 22.43, 22.24, 13.9, 13.7 
HRMS calculated for C18H24ClO [M+H]+: 291.1510, Found: 291.1521 
 
1HNMR (400 MHz; CDCl3): δ 7.60-7.57 (m, 1H), 7.49 (m, 1H), 7.26 (m, 1H), 7.09-7.06 (m, 
1H), 4.92 (tt, J = 6.5, 3.2 Hz, 1H), 3.54 (d, J = 2.0 Hz, 2H), 1.84 (td, J = 7.4, 3.1 Hz, 2H), 1.66 
(m, 2H), 1.27-1.22 (m, 2H), 1.17-1.10 (m, 4H), 0.70 (m, 6H). 
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13CNMR (100 MHz; CDCl3): δ 202.7, 196.82-196.80 (d, JC-F= 2.2 Hz), 164.0, 161.5, 130.03-
129.95 (d, JC-F= 7.4 Hz), 124.47-124.44 (d, JC-F= 2.9 Hz), 120.0-119.7 (d, JC-F= 21.5 Hz), 115.5-
115.3(d, JC-F= 22.4 Hz), 98.6, 92.84-92.82(d, JC-F= 2.7 Hz), 43.9, 32.2, 30.9, 29.6, 22.42, 22.26, 
13.9, 13.7 
HRMS calculated for C18H24FO [M+H]+: 275.1806, Found: 275.1816 
 
1HNMR (400 MHz; CDCl3): δ 8.08 (dd, J = 2.9, 1.2 Hz, 1H), 7.55 (dd, J = 5.1, 1.2 Hz, 1H), 
7.30-7.26 (m, 1H), 5.11 (m, 1H), 3.46 (d, J = 2.2 Hz, 2H), 2.01 (m, J = 3.7 Hz, 2H), 1.87 (q, J = 
7.3 Hz, 2H), 1.45-1.37 (m, 2H), 1.35-1.24 (m, 4H), 0.88 (m, 6H). 
13CNMR (100 MHz; CDCl3): δ 202.6, 192.2, 141.7, 132.4, 127.2, 125.8, 98.7, 92.3, 45.1, 31.9, 
30.9, 29.5, 22.31, 22.12, 13.8, 13.6 
HRMS calculated for C16H23OS [M+H]+: 263.1464, Found: 263.1474 
 
1HNMR (400 MHz; CDCl3): δ 7.91-7.89 (m, 2H), 7.44 (tt, J = 7.4, 1.6 Hz, 1H), 7.34-7.31 (m, 
3H), 7.24 (m, 2H), 7.13-7.09 (m, 1H), 3.92 (s, 2H), 1.93 (m, 2H), 1.85 (m, 2H), 1.47-1.41 (m, 
2H), 1.36 (m, 2H), 1.27-1.22 (m, 2H). 
13CNMR (100 MHz; CDCl3): δ 199.7, 198.2, 137.2, 136.4, 132.8, 128.8, 128.36, 128.33, 126.5, 
125.6, 107.3, 98.6, 41.5, 30.7, 27.3, 25.9 
nBu
O
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HRMS calculated for C22H23O [M+H]+: 303.1743, Found: 303.1756 
 
1HNMR (400 MHz; CDCl3): δ 7.35-7.27 (m, 4H), 7.20-7.16 (m, 1H), 3.43 (s, 2H), 2.50 (t, J = 
7.5 Hz, 2H), 2.30-2.17 (m, 4H), 1.72-1.66 (m, 4H), 1.62-1.50 (m, 4H), 1.30-1.24 (m, 2H), 0.87 
(t, J = 8.4 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 209.9, 199.8, 137.2, 128.5, 126.5, 125.7, 106.2, 97.8, 46.3, 41.0, 
31.2, 27.7, 26.13, 26.00, 22.4, 13.9 
HRMS calculated for C20H27O [M+H]+: 283.2056, Found: 283.2067 
 
1HNMR (400 MHz; CDCl3): δ 7.76 (m, J = 1.0 Hz, 1H), 7.67 (m, J = 1.6 Hz, 1H), 7.42-7.37 (m, 
3H), 7.34-7.30 (m, 2H), 7.25-7.18 (m, 2H), 3.99 (s, 2H), 2.06-2.00 (m, 2H), 1.93 (m, J = 4.7 Hz, 
2H), 1.54 (m, J = 4.5 Hz, 2H), 1.46 (m, 2H), 1.37 (m, J = 4.0 Hz, 2H). 
13CNMR (100 MHz; CDCl3): δ 199.7, 196.9, 163.96-161.50 (d, JC-F= 246.2 Hz), 138.56-138.50 
(d, JC-F= 6.1 Hz), 136.9, 130.02-129.94 (d, JC-F= 7.5 Hz), 128.4, 126.6, 125.6, 124.64-124.61 (d, 
JC-F= 2.9 Hz), 119.91-119-70 (d, JC-F= 21.3 Hz), 115.55-115-33 (d, JC-F= 22.1 Hz), 107.5, 98.4, 
41.6, 30.6, 27.3, 25.9 
HRMS calculated for C22H22FO [M+H]+: 321.1649, Found: 321.1661 
O
nBu
O
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1HNMR (400 MHz; CDCl3): δ 7.34-7.26 (m, 4H), 7.19-7.15 (m, 1H), 3.47 (d, J = 6.7 Hz, 2H), 
2.62 (tt, J = 10.6, 3.3 Hz, 1H), 2.31-2.17 (m, 4H), 1.84-1.75 (m, 4H), 1.72-1.57 (m, 6H), 1.38-
1.19 (m, 6H). 
13CNMR (100 MHz; CDCl3): δ 212.7, 199.8, 137.2, 128.4, 126.4, 125.7, 106.0, 97.6, 48.7, 44.5, 
31.2, 28.6, 27.6, 26.05, 25.85, 25.72 
HRMS calculated for C22H29O [M+H]+: 309.2213, Found: 309.2225 
 
1HNMR (400 MHz; CDCl3): δ 7.91-7.88 (m, 2H), 7.46-7.42 (m, 1H), 7.36-7.32 (m, 2H), 3.45 (s, 
2H), 1.93 (t, J = 7.2 Hz, 2H), 1.82 (m, 4H), 1.36-1.21 (m, 10H), 0.80 (t, J = 7.2 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 198.5, 197.1, 136.5, 132.7, 128.8, 128.2, 104.3, 96.9, 44.4, 32.5, 
31.3, 29.6, 27.5, 26.1, 22.1, 14.0 
HRMS calculated for C20H27O [M+H]+: 283.2056, Found: 283.2065 
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1HNMR (400 MHz; CDCl3): δ 7.91 (dd, J = 8.3, 1.0 Hz, 2H), 7.43 (dd, J = 8.3, 1.0 Hz, 2H), 3.50 
(s, 2H), 1.99 (t, J = 7.0 Hz, 2H), 1.90 (m, 4H), 1.48-1.37 (m, 8H), 1.34-1.31 (m, 11H), 0.88 (m, 
3H). 
13CNMR (100 MHz; CDCl3): δ 198.3, 197.1, 156.4, 134.0, 128.8, 125.2, 104.2, 97.1, 44.4, 40.6, 
32.6, 31.3, 31.1, 29.7, 27.5, 26.1, 22.2, 14.0 
HRMS calculated for C24H35O [M+H]+: 339.2682, Found: 339.2695 
 
1HNMR (400 MHz; CDCl3): δ 7.97-7.95 (m, 2H), 7.53-7.51 (m, 1H), 7.45-7.41 (m, 2H), 3.52 (s, 
2H), 1.98 (t, J = 7.0 Hz, 2H), 1.49-1.48 (s, 6H), 1.39-1.25 (m, 4H), 0.88 (t, J = 7.1 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 200.8, 198.6, 136.6, 132.7, 128.8, 128.3, 97.02, 96.85, 44.1, 
32.6, 29.6, 22.2, 20.1, 14.0 
HRMS calculated for C17H23O [M+H]+: 243.1743, Found: 243.1752 
 
1HNMR (400 MHz; CDCl3): δ 7.31 (m, 2H), 7.26 (m, 1H), 7.20-7.18 (m, 2H), 3.76 (s, 2H), 3.00 
(s, 2H), 1.89 (t, J = 6.7 Hz, 2H), 1.71 (s, 6H), 1.33-1.31 (m, 4H), 0.88 (t, J = 7.1 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 206.5, 200.5, 134.4, 129.5, 128.6, 126.9, 96.5, 96.1, 48.4, 47.2, 
32.7, 29.6, 22.2, 20.6, 14.0 
HRMS calculated for C18H25O [M+H]+: 257.1900, Found: 257.1909 
nBu
O
nBu
O
! 51!
 
1HNMR (400 MHz; CDCl3): δ 7.74 (m, J = 1.0 Hz, 1H), 7.64 (m, J = 1.6 Hz, 1H), 7.41 (m, 1H), 
7.25-7.21 (m, 1H), 3.50 (s, 2H), 1.98 (t, J = 7.2 Hz, 2H), 1.51 (s, 6H), 1.39-1.28 (m, 4H), 0.88 (t, 
J = 7.2 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 200.9, 197.279-129.260 (d, JC-F= 1.9 Hz), 163.9, 138.7, 129.936-
129.860 (d, JC-F= 7.6Hz), 124.508-124.480 (d, JC-F= 2.8 Hz), 119.780-119.564 (d, JC-F= 21.6Hz), 
115.609-115.389 (d, JC-F= 22 Hz), 97.158, 96.791, 44.2, 32.5, 29.6, 22.2, 20.1, 14.0  
HRMS calculated for C17H22FO [M+H]+: 261.1649, Found: 261.1660 
 
1HNMR (400 MHz; CDCl3): δ 7.98-7.96 (m, 2H), 7.54 (m, 1H), 7.45 (m, 2H), 5.23 (m, 1H), 3.63 
(d, J = 6.9 Hz, 2H), 1.63 (d, J = 2.9 Hz, 6H). 
13CNMR (100 MHz; CDCl3): δ 203.4, 198.2, 136.4, 132.9, 128.4, 128.1, 96.4, 82.6, 39.8, 20.2 
HRMS calculated for C13H15O [M+H]+: 187.1117, Found: 187.1118. 
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1HNMR (400 MHz; CDCl3): δ 8.19-8.17 (m, 2H), 7.54-7.52 (m, 2H), 7.35-7.31 (m, 4H), 7.28-
7.26 (m, 1H), 6.64 (s, 1H), 3.68 (dd, J1= 16.4 Hz, J2= 1.6 Hz 1H), 3.65 (dd, J1= 16.4 Hz, J2= 1.6 
Hz 1H), 2.56 (t, J = 7.4 Hz, 2H), 1.58 (m, 2H), 1.28 (m, 2H), 0.87 (t, J = 7.3 Hz, 3H). 
13CNMR (100 MHz; CDCl3): δ 209.9, 207.2, 146.8, 140.9, 133.8, 128.8, 127.9, 127.5, 126.0, 
124.1, 105.0, 96.6, 44.7, 42.0, 25.8, 22.2, 13.8 
HRMS calculated for C21H22NO3 [M+H]+: 336.1594, Found: 336.1595. 
 
Supporting information for furan synthesis !
General procedure for furan synthesis !
 
Figure 47. General reaction for furan synthesis 
 
Alkyne 2a (1.6 mmol) and gold catalyst (0.01 mmol) in toluene (1.5 ml) was added to a 
solution of 1a (1 mmol). Then the copper catalyst (0.005 mmol) added to the mixture. The 
mixture stirred and heated on 45 oC and monitored by TLC. After the completion of the 
consumption of the propargyl alcohol, the mixture was directly loaded on column 
chromatography on silica gel for purification by hexane/ethyl acetate (50:1) to give the desired 
product. 
Characterization data for furan synthesis 
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1HNMR (400 MHz; CDCl3): δ 7.68 (m, 2H), 7.41-7.3 (m, 8H), 6.75 (s, 1H), 2.84 (t, J = 7.6 Hz, 
2H), 1.75 (m, 2H), 1.42 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 151.8, 151.5, 134.2, 131.7, 128.6, 128.2, 127.6, 126.9, 126.4, 
123.4, 122.6, 106.5, 30.8, 26.8, 22.5, 18.6. 
HRMS calculated for C20H21O [M+H]+: 277.1586, Found: 277.1586 
 
1HNMR (400 MHz; CDCl3): δ  7.64 (t, J = 1.8 Hz, 1H), 7.55-7.52 (m, 1H), 7.41-7.39 (m, 4H), 
7.30 (m, 2H), 7.21-7.20 (m, 1H), 6.77 (s, 1H), 2.82 (t, J = 7.7 Hz, 2H), 1.72 (m, 2H), 1.40 (m, 
2H), 0.93 (t, J = 7.4 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 152.5, 150.1, 134.7, 133.9, 132.6, 129.9, 129.6, 127.7, 126.8, 
126.6, 123.4, 123.1, 121.4, 107.7, 30.7, 26.8, 22.5, 13.8. 
HRMS calculated for C20H20ClO [M+H]+: 311.1197, Found: 311.1198. 
  
1HNMR (400 MHz; CDCl3): δ 7.35-7.34 (m, 3H), 7.24-7.22 (m, 2H), 6.07 (s, 1H), 2.72 (t, J = 
7.7 Hz, 2H), 2.60 (t, J = 7.6 Hz, 2H), 1.69-1.63 (m, 4H), 1.39 (m, 4H), 0.91 (m, 6H). 
13CNMR (101 MHz; CDCl3): δ 149.9, 134.8, 129.4, 128.4, 128.1, 127.5, 126.0, 106.1, 31.1, 
30.8, 30.14, 27.7, 26.7, 26.1, 22.4, 13.8. 
HRMS calculated for C18H25O [M+H]+: Exact Mass: 257.1900, Found: 257.1907. 
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1HNMR (400 MHz; CDCl3): δ  7.39-7.33 (m, 4H), 7.22 (t, J = 4.2 Hz, 1H), 6.05 (s, 1H), 2.74 (t, 
J = 7.7 Hz, 2H), 2.60 (m, 1H), 2.04-1.86 (m, 2H), 1.86-1.83 (m, 2H), 1.70-1.62 (m, 4H), 1.41-
1.34 (m, 6H), 0.90 (t, J = 7.4 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 158.7, 149.7, 134.9, 128.4, 127.5, 126.0, 120.8, 104.1, 37.2, 
31.5, 30.8, 26.7, 26.2, 26.0, 22.5, 13.9. 
HRMS calculated for C20H27O [M+H]+: 283.2056, Found: 283.2054 
 
1HNMR (400 MHz; CDCl3): δ  7.39-7.37 (m, 4H), 7.25 (t, J = 4.2 Hz, 1H), 6.08 (s, 1H), 2.78 (t, 
J = 7.7 Hz, 2H), 1.70 (m, 2H), 1.41 (m, 2H), 1.34 (s, 9H), 0.94 (t, J = 7.4 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 149.8, 134.9, 128.4, 127.5, 126.0, 120.7, 103.3, 32.5, 30.7, 29.9, 
26.7, 22.45, 13.9. 
HRMS calculated for C18H25O [M+H]+: 256.1827, Found: 256.1857 
 
1HNMR (400 MHz; CDCl3): δ  7.61 (m, 2H), 7.35-7.31 (m, 2H), 7.18-7.16 (m, 1H), 6.46 (s, 1H), 
2.61 (t, J = 7.5 Hz, 2H), 2.35 (t, J = 7.5 Hz, 2H), 1.65-1.61 (m, 2H), 1.54-1.50 (m, 2H), 1.38-
1.33 (m, 4H), 0.93 (m, 6H). 
13CNMR (101 MHz; CDCl3): δ 151.3, 150.9, 131.4, 128.5, 126.4, 123.1, 121.2, 107.1, 32.8, 
31.0, 29.7, 25.8, 24.5, 22.3, 13.95, 13.88 
HRMS calculated for C18H25O [M+H]+: 257.1900, Found: 257.1908. 
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1HNMR (400 MHz; CDCl3): δ  7.6 (m, 2H), 7.32 (m, 2H), 7.19 (m, 1H), 6.46 (s, 1H), 2.60 (t, J = 
7.5 Hz, 2H), 2.34 (t, J = 7.4 Hz, 2H), 1.65-1.62 (m, 2H), 1.54-1.51 (m, 2H), 1.38-1.34 (m, 4H), 
0.94 (m, 6H). 
13CNMR (101 MHz; CDCl3): δ 151.7, 150.9, 131.4, 128.5, 126.4, 126.1, 123.1, 121.2, 120.2, 
107.0, 32.7, 30.9, 29.7, 25.8, 24.4, 22.3, 13.9. 
HRMS calculated for C18H24FO [M+H]+: 275.1806, Found: 275.1816 
 
1HNMR (400 MHz; CDCl3): δ  7.57 (t, J = 1.7 Hz, 1H), 7.44 (dt, J = 7.8, 1.2 Hz, 1H), 7.27-7.23 
(m, 1H), 7.14 (m, J = 1.0 Hz, 1H), 6.48 (s, 1H), 2.59 (t, J = 7.5 Hz, 2H), 2.33 (t, J = 7.5 Hz, 2H), 
1.61 (m, 2H), 1.54-1.50 (m, 2H), 1.37 (m, 4H), 0.92 (m, 6H). 
13CNMR (101 MHz; CDCl3): δ 152.0, 149.5, 134.5, 133.0, 129.8, 126.3, 123.1, 121.5, 121.2, 
108.2, 32.6, 30.9, 29.7, 25.8, 24.4, 22.3, 13.90. 
HRMS calculated for C18H24ClO [M+H]+: 291.1510, Found: 291.1521. 
 
1HNMR (400 MHz; CDCl3): δ  7.35-7.33 (m, 1H), 7.27 (m, 1H), 7.26-7.25 (m, 1H), 6.28 (s, 1H), 
2.58 (t, J = 7.5 Hz, 2H), 2.33 (t, J = 7.5 Hz, 2H), 1.61 (m, 2H), 1.49 (m, 2H), 1.35 (m, 4H), 0.91 
(m, 6H). 
13CNMR (101 MHz; CDCl3): δ 150.5, 148.1, 133.2, 125.8, 124.5, 120.7, 117.3, 106.8, 32.7, 
31.0, 25.8, 24.4, 22.3, 13.95, 13.87 
HRMS calculated for C16H23OS [M+H]+: 263.1464, Found: 263.1474 
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1HNMR (400 MHz; CDCl3): δ 5.75 (s, 1H), 2.48 (t, J = 7.5 Hz, 2H), 2.25 (t, J = 7.5 Hz, 2H), 
1.61-1.52 (m, 6H), 1.45 (m, 2H), 1.34-1.25 (m, 4H), 0.92 (m, 6H). 
13CNMR (101 MHz; CDCl3): δ 153.3, 149.06, 119.1, 106.4, 32.8, 31.1, 30.1, 29.7, 25.6, 24.5, 
22.4, 22.3, 21.4, 13.8, 13.87 
HRMS calculated for C16H29O [M+H]+: 236.3990, Found: 236.4004 
 
1HNMR (400 MHz; CDCl3): δ 5.71 (s, 1H), 2.48 (m, 3H), 2.25 (t, J = 7.5 Hz, 2H), 2.00 (m, 2H), 
1.74 (m, 2H), 1.58 (m, 2H), 1.55 (m, 2H), 1.33 (m, 2H), 129-122 (m, 9H), 0.92-0.84 (m, 6H). 
13CNMR (101 MHz; CDCl3): δ 158.0, 148.7, 118.8, 104.16, 37.2, 32.8, 31.6, 31.1, 26.2, 26.0, 
25.7, 24.5, 22.5, 22.3, 13.9, 13.8 
HRMS calculated for C18H31O [M+H]+: 262.2297, Found: 262.2300. 
 
1HNMR (400 MHz; CDCl3): δ 7.76-7.74 (m, 2H), 7.49-7.34 (m, 6H), 7.30 (m, 2H), 6.85 (s, 1H), 
2.57 (s, 3H). 
13CNMR (101 MHz; CDCl3): δ 151.7, 147.6, 134.12, 130.9, 128.7, 127.5, 127.1, 126.5, 123.5, 
123.1, 106.5, 13.2. 
HRMS calculated for C17H15O [M+H]+: 234.1045, Found: 234.1040. 
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1HNMR (400 MHz; CDCl3): δ 7.38-7.43 (m, 5H), 7.30 (m, 2H), 7.22 (m, 1H), 6.58 (s, 1H), 2.48 
(s, 3H). 
13CNMR (101 MHz; CDCl3): δ 148.9, 146.8, 132.5, 128.6, 127.4, 127.0, 126.4, 126.1, 124.5, 
122.5, 118.2, 106.2, 13.1. 
HRMS calculated for C15H13OS [M+H]+: 240.0609, Found: 240.0619. 
 
1HNMR (400 MHz; CDCl3): δ 7.41-7.39 (m, 4H), 7.26-7.25 (m, 1H), 6.10 (s, 1H), 2.62 (m, 1H), 
2.44 (s, 3H), 2.09-2.06 (m, 2H), 1.84 (m, 2H), 1.75 (m, 1H), 1.41-1.38 (m, 5H). 
13CNMR (101 MHz; CDCl3): δ 158.8, 145.4, 134.7, 128.4, 127.3, 125.9, 121.0, 104.1, 37.2, 
31.6, 26.15, 25.99, 13.0 
HRMS calculated for C17H21O [M+H]+: 240.1514, Found: 240.1516. 
 
1HNMR (400 MHz; CDCl3): δ 7.41-7.38 (m, 4H), 7.25-7.23 (m, 1H), 6.19 (s, 1H), 3.61 (s, 2H). 
2.85-2.79 (m, 2H), 2.43 (s, 3H), 2.18-2.11 (m, 2H). 
13CNMR (101 MHz; CDCl3): δ 162.3, 152.0, 134.3, 128.5, 127.3, 126.1, 121.3, 107.1, 44.2, 
30.9, 27.6, 25.1. 
HRMS calculated for C14H16ClO [M+H]+: 234.0811, Found: 234.0808. 
 
1HNMR (400 MHz; CDCl3): δ  7.63 (m, 2H), 7.36-7.33 (m, 2H), 7.22-7.18 (m, 1H), 6.54 (d, J = 
3.2 Hz, 1H), 6.05-6.04 (dt, J = 3.4, 1.0 Hz, 1H), 2.67 (t, J = 7.6 Hz, 2H), 1.68 (m, 2H), 1.35-1.26 
(m, 8H), 0.88 (t, J = 7.1 Hz, 3H). 
O
Ph
Cy
O
Ph
Cl
3
On-Hept
Ph
! 58!
13CNMR (101 MHz; CDCl3): δ 156.5, 152.0, 131.3, 128.5, 126.7, 123.3, 106.8, 105.6, 31.8, 
29.2, 29.0, 28.2, 28.1, 22.7, 14.1 
HRMS calculated for C17H23O [M+H]+: 242.1671, Found: 242.1675. 
 
1HNMR (400 MHz; CDCl3): δ  7.63 (m, 2H), 7.35-7.31 (m, 2H), 7.23-7.19 (m, 1H), 6.54 (d, J = 
3.2 Hz, 1H), 6.06-6.05 (dt, J = 3.4, 1.0 Hz, 1H), 2.69 (t, J = 7.6 Hz, 2H), 1.67 (m, 2H), 1.43 (m, 
2H), 0.98 (t, J = 7.0 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 156.5, 152.1, 132.1, 128.5, 126.6, 123.3, 106.8, 105.6, 30.2, 
27.7, 22.3, 13.8 
HRMS calculated for C14H17O [M+H]+: 200.1201, Found: 200.1209. 
 
1HNMR (400 MHz; CDCl3): δ  7.40-7.36 (m, 2H), 7.29-7.27 (m, 3H), 2.58 (t, J = 7.6 Hz, 2H), 
2.35-2.32 (t, J = 7.0 Hz, 2H), 2.23 (s, 3H), 1.63 (m, 2H), 1.41 (m, 2H), 1.21 (m, 4H), 0.96 (m, 
3H), 0.80-0.77 (m, 3H). 
13CNMR (101 MHz; CDCl3): δ 149.4, 145.4, 134.7, 129.3, 128.2, 126.2, 122.1, 118.9, 32.7, 
31.1, 26.0, 23.2, 22.5, 22.4, 13.9, 13.7, 12.1. 
HRMS calculated for C19H27O [M+H]+: 270.1984, Found: 270.1998.  
 
1HNMR (400 MHz; CDCl3): δ 7.25-7.19 (m, 8H), 7.05 (m, 2H), 2.33 (s, 6H). 
13CNMR (101 MHz; CDCl3): δ 146.3, 129.6, 128.5, 128.0, 126.7, 126.23, 12.3 
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HRMS calculated for C18H17O [M+H]+: 248.1201, Found: 248.1211. 
 
1HNMR (400 MHz; CDCl3): δ 7.25-7.23 (m, 6H), 7.05 (m, 4H), 2.64 (t, J = 7.7 Hz, 2H), 2.34 (s, 
3H), 1.68-1.64 (m, 2H), 1.38-1.32 (m, 2H), 0.89 (t, J = 7.4 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 150.6, 133.7, 133.6, 131.4, 129.7, 129.6, 128.8, 128.0, 127.9, 
126.2, 126.0, 31.0, 26.2, 22.5, 13.8. 12.4. 
HRMS calculated for C21H23O [M+H]+: 290.1671, Found: 290.1671. 
Supporting information for synthesis of oxepine derivatives  !
General procedure for synthesizing compounds 21. !
 
Figure 48. General reaction for synthesis of compound 21 !
To a 25 ml vial, 2 (1 mmol) was added to a solution of 3 (3 mmol) and gold catalyst (0.05 
mmol) in toluene solvent (10 ml) under argon protection. The mixture was stirred for about 15 
minutes until the gold catalyst dissolve in the solvent. After that, the copper (0.01 mmol) was 
added to the mixture and the solutio was stirred at ambient temperature for 24 hours. The 
resulting mixture was then passed through a short pad of silica and collected in a separate vial. 
The silica pad was rinsed with 1 ml of toluene into the reaction mixture. The dienophile (1.5 
mmol) was added to the solution and the vial was attached to high vacuum at 45 oC until the 
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volume of the solvent decrease by 2 ml (20% of the initial volume). Then the mixture was 
flushed with argon for 2-3 minutes. The resulting mixture was stirred at 45 oC for 24 hours. After 
that, the reaction mixture was loaded on silica gel column chromatography for purification by 
hexane/ethyl acetate (5:1) to give the desired product. 
General procedure for synthesizing compounds 22. !!!
!
Figure 49. General reaction for synthesis of compound 21 
 
To a 25 ml vial, 2 (1 mmol) was added to a solution of 3 (3 mmol) and gold catalyst (0.05 
mmol) in toluene solvent (10 ml) under argon protection. The mixture was stirred for about 15 
minutes until the gold catalyst dissolve in the solvent. After that, the copper (0.01 mmol) was 
added to the mixture and the solutio was stirred at ambient temperature for 24 hours. The 
resulting mixture was then passed through a short pad of silica and collected in a separate vial. 
The silica pad was rinsed with 1 ml of toluene into the reaction mixture. Then dienophile (1.5 
mmol) was added to the solution and the vial was attached to high vacuum at 60 oC until the 
volume of the solvent decrease by 2 ml (25% of the initial volume). Then the mixture was 
flushed with argon for 2-3 minutes. The resulting mixture was stirred at 75 oC for 24 hours. After 
that, the reaction mixture was directly loaded on silica gel column chromatography for 
purification by hexane/ethyl acetate (5:1) as solvent to isolate the desired product. 
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Chirality transfer experiment 
 
     
Figure 50. General reaciton for chirality transfer to compound 21 
 
Chirality transfer performed by general procedure 2. Enantiomeric excess of 
homopropargyl alcohol was determined by HPLC with chiralcel OD-H column; λ = 254 nm; 
eluent: Hexane/Isopropanol = 90/10; Flow rate: 1ml/min; t = 8.49 min, t = 12.83 min, 99% ee.  
 
Enantiomeric excess of final product was determined by HPLC with chiralcel OD-H 
column; λ = 210 nm; eluent: Hexane/Isopropanol = 90/10; Flow rate: 1ml/min; t = 12.97 min, t = 
20.00 min, 99% ee.  
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Crystal structure of 21b 
 
Figure 51. Perspective view of the molecular structure of C22H24O4. 
 
CCDC 1449159.  
Crystal structure of 21m 
 
 
Figure 52. Perspective view of the molecular structure of C21H16N4O.  
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Crystal structure of 21q 
 
Figure 53. Perspective view of the molecular structure of C25H22N4O. !
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Crystal structure of 22e !
 
Figure 54. Perspective view of the molecular structure of C19H18O4. !
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Crystal structure of 22m 
 
Figure 55. Perspective view of the molecular structure of C20H20O4.  !
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Figure 56. Perspective view of the molecular structure of C23H24O4.  !
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Compound characterization data of oxepine derivatives !
 
1HNMR (400 MHz; CDCl3): δ 7.40-7.35 (m, 5H), 6.11 (s, 1H), 3.81-3.75 (m, 2H), 3.71-3.65 (m, 
2H), 3.56 (dd, J = 8.8, 1.8 Hz, 1H), 2.04-2.00 (m, 1H), 1.96-1.88 (m, 2H), 1.83 (m, J = 1.8 Hz, 
1H), 1.62-1.53 (m, 2H), 1.45-1.39 (m, 2H), 0.99-0.95 (t, J = 7.2 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 173.0, 169.3, 144.2, 137.3, 128.9, 125.7, 124.88, 124.75, 77.3, 
62.3, 51.8, 47.9, 38.65, 38.52, 31.2, 25.0, 23.0, 14.1 
HRMS calculated for C20H23O4 [M+H]+: 327.1596, Found: 327.1597. 
 
1HNMR (400 MHz; CDCl3): δ  7.36 (m, 5H), 6.22 (s, 1H), 3.93 (d, J = 8.8 Hz, 1H), 3.76 (m, 
2H), 3.62-3.52 (m, 2H), 2.05 (d, J = 8.8 Hz, 1H), 1.94 (m, 2H), 1.83 (m, 4H), 1.72 (m, 1H), 1.39-
1.31 (m, 4H), 1.26-1.20 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 173.2, 169.0, 143.7, 137.5, 128.89, 128.85, 125.7, 124.8, 79.7, 
62.4, 49.8, 48.0, 43.9, 39.04, 38.93, 31.6, 26.41, 26.22, 26.09, 25.9 
HRMS calculated for C22H25O4 [M+H]+: 353.1753, Found: 353.1752.  
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1HNMR (400 MHz; CDCl3): δ  7.39-7.35 (m, 5H), 6.17 (d, J = 1.3 Hz, 1H), 3.83-3.79 (m, 1H), 
3.76-3.72 (m, 2H), 3.63 (td, J = 12.1, 3.8 Hz, 1H), 3.55 (dd, J = 8.9, 1.7 Hz, 1H), 2.62 (quintet, J 
= 8.3 Hz, 1H), 1.99-1.90 (m, 2H), 1.84-1.77 (m, 2H), 1.68-1.63 (m, 4H), 1.28-1.26 (m, 1H), 
0.90-0.87 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 173.1, 169.2, 143.7, 137.4, 128.89, 128.73, 125.39, 125.22, 78.3, 
62.7, 60.3, 51.7, 48.1, 46.0, 38.8, 31.4, 26.2, 20.9, 14.1 
HRMS calculated for C21H23O4 [M+H]+: 339.1596, Found: 339.1597.  
 
1HNMR (400 MHz; CDCl3): δ 7.39-7.36 (m, 5H), 6.15 (d, J = 1.3 Hz, 1H), 3.75 (2H), 3.71-3.67 
(m, 2H), 3.55 (dd, J = 8.8, 1.7 Hz, 1H), 1.97 (m, 1H), 1.89-1.84 (m, 4H), 1.72-1.67 (m, 4H), 
1.31-1.24 (m, 4H), 1.11-1.07 (m, 3H). 
13CNMR (101 MHz; CDCl3): δ 173.0, 169.4, 143.7, 137.4, 128.9, 125.6, 125.23, 125.22, 78.0, 
62.1, 53.1, 48.0, 45.6, 38.8, 35.1, 34.8, 33.9, 31.4, 26.5, 26.3 
HRMS calculated for C23H27O4 [M+H]+: 367.1909, Found: 367.1917. 
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1HNMR (400 MHz; CDCl3): δ  7.30 (d, J = 8.2 Hz, 2H), 7.19-7.17 (d, J = 8.2 Hz, 2H), 6.08 (d, J 
= 1.4 Hz, 1H), 3.76-3.73 (m, 2H), 3.68 (m, 2H), 3.54 (dd, J = 8.8, 1.8 Hz, 1H), 2.40 (m, 1H), 
2.36 (s, 3H), 1.99-1.90 (m, 2H), 1.59-1.57 (m, 2H), 1.44-1.40 (m, 2H), 0.99-0.95 (t, J = 7.2 Hz, 
3H). 
13CNMR (101 MHz; CDCl3): δ 173.0, 169.4, 144.0, 139.0, 134.4, 129.6, 125.5, 123.8, 77.3, 
62.2, 51.9, 47.9, 38.61, 38.55, 31.2, 25.0, 23.0, 21.2, 14.1 
HRMS calculated for C21H25O4 [M+H]+: 341.1753, Found: 341.1765.  
 
1HNMR (500 MHz; CDCl3): δ 7.63 (d, J = 8.2 Hz, 2H), 7.50 (d, J = 8.2 Hz, 2H), 6.20 (d, J = 1.4 
Hz, 1H), 3.82 (m, J = 1.7 Hz, 1H), 3.76-3.74 (m, 2H), 3.66 (ddd, J = 12.7, 11.2, 4.0 Hz, 1H), 
3.59 (dd, J = 8.9, 1.9 Hz, 1H), 2.05-2.02 (m, 1H), 1.99-1.92 (m, 2H), 1.85-1.81 (m, 1H), 1.62-
1.59 (m, 2H), 1.45-1.40 (m, 2H), 1.00-0.95 (t, J = 7.1 Hz, 3H). 
13CNMR (126 MHz; CDCl3): δ 172.8, 169.0, 143.3, 140.8, 130.5, 127.2, 126.05, 125.88, 62.4, 
51.6, 47.9, 38.7, 38.5, 31.0, 29.7, 25.0, 23.0, 14.1 
HRMS calculated for C21H22F3O4 [M+H]+: 395.1470, Found: 395.1473.  
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1HNMR (400 MHz; CDCl3): δ 7.37-7.27 (m, 4H), 6.14 (d, J = 1.3 Hz, 1H), 3.80 (m, J = 1.6 Hz, 
1H), 3.69 (m, 2H), 3.68-3.62 (m, 1H), 3.56 (dd, J = 8.9, 1.8 Hz, 1H), 2.04-1.98 (m, 2H), 1.97-
1.90 (m, 2H), 1.85-1.79 (m, 1H), 1.53-1.49 (m, 1H), 1.46-1.39 (m, 2H), 0.97 (m, J = 7.2 Hz, 
3H). 
13CNMR (101 MHz; CDCl3): δ 172.8, 169.1, 143.1, 139.2, 134.9, 130.2, 128.9, 126.1, 125.8, 
123.8, 77.3, 62.3, 51.7, 47.8, 38.63, 38.46, 31.0, 25.0, 23.0, 14.1 
HRMS calculated for C20H22ClO4 [M+H]+: 361.1207, Found: 361.1212.  
 
1HNMR (400 MHz; CDCl3): δ 7.36 (m, 5H), 5.99 (s, 1H), 3.72 (m, J = 4.7 Hz, 4H), 3.42 (d, J = 
7.8 Hz, 1H), 3.25 (d, J = 7.7 Hz, 1H), 2.85 (s, 3H), 2.00 (m, 2H), 1.80 (m, 1H), 1.64 (m, 2H), 
1.44 (m, 2H), 0.98 (t, J = 7.2 Hz, 3H). 
13CNMR (126 MHz; CDCl3): δ 178.7, 175.9, 143.7, 138.1, 128.7, 128.4, 125.7, 124.7, 77.6, 
62.2, 51.3, 47.4, 38.8, 38.2, 31.3, 25.3, 24.9, 23.1, 14.2 
HRMS calculated for C21H26NO3 [M+H]+: 340.1913, Found: 340.1921.  
 
O
n-Bu
O
O
O
Cl
O
nBu
MeN
PhO
O
! 69!
 
1HNMR (400 MHz; CDCl3): δ 7.32 (m, 5H), 6.07 (d, J = 0.9 Hz, 1H), 3.72 (m, 2H), 3.64 (d, J = 
7.8 Hz, 1H), 3.57 (td, J = 12.0, 3.8 Hz, 1H), 3.21 (d, J = 7.7 Hz, 1H), 2.82 (s, 3H), 2.16-2.13 (m, 
1H), 2.01-1.95 (m, 1H), 1.83 (m, 3H), 1.72 (m, 2H), 1.34 (m, 4H), 1.27-1.18 (m, 2H). 
13CNMR (126 MHz; CDCl3): δ 179.0, 175.7, 143.2, 138.3, 128.7, 128.4, 125.6, 124.7, 80.0, 
62.2, 49.2, 47.6, 44.3, 38.5, 31.7, 26.6, 26.3, 26.0, 24.8 
HRMS calculated for C23H28NO3 [M+H]+: 366.2069, Found: 366.2072.  
 
1HNMR (400 MHz; CDCl3): δ 7.48 (s, 5H), 6.34 (d, J = 1.4 Hz, 1H), 4.03-3.99 (m, 2H), 3.63 (td, 
J = 12.2, 4.1 Hz, 1H), 2.77 (m, J = 6.7, 1.2 Hz, 1H), 2.23-2.09 (m, 2H), 1.97 (m, J = 3.8 Hz, 1H), 
1.53-1.43 (m, 4H), 0.99 (t, J = 7.2 Hz, 3H). 
13CNMR (151 MHz; CDCl3): δ 143.9, 135.2, 130.5, 129.5, 125.7, 122.0, 112.7, 111.6, 111.0, 
110.6, 82.3, 62.4, 53.5, 46.9, 45.7, 38.1, 29.1, 24.8, 22.6, 13.9 
HRMS calculated for C22H21N4O [M+H]+: 357.1715, Found: 357.1720.  
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1HNMR (400 MHz; CDCl3): δ 7.47 (s, 5H), 6.34 (d, J = 1.2 Hz, 1H), 4.02 (m, 2H), 3.63 (td, J = 
12.2, 4.1 Hz, 1H), 2.76 (m, J = 6.6, 1.3 Hz, 1H), 2.14-2.08 (m, 2H), 2.04-1.89 (m, 2H), 1.77-1.74 
(m, 1H), 1.40-1.35 (m, 2H), 1.31-1.19 (m, 2H), 0.90-0.86 (m, 1H). 
13CNMR (151 MHz; CDCl3): δ 144.2, 135.5, 130.4, 129.5, 125.7, 121.6, 112.7, 111.33, 111.26, 
110.8, 84.5, 62.6, 51.7, 47.0, 46.8, 46.71, 28.8, 27.3, 26.5, 25.9, 25.8, 25.7 
HRMS calculated for C24H23N4O [M+H]+: 383.1872, Found: 383.1794. 
 
1HNMR (400 MHz; CDCl3): δ 7.47 (s, 5H), 6.37 (d, J = 1.3 Hz, 1H), 4.02 (d, J = 7.0 Hz, 1H), 
3.88 (dd, J = 12.6, 6.4 Hz, 1H), 3.55-3.48 (m, 2H), 2.69 (ddd, J = 15.7, 11.7, 6.5 Hz, 1H), 1.93 
(ddd, J = 15.7, 7.0, 3.9 Hz, 1H), 1.60 (tt, J = 8.1, 5.1 Hz, 1H), 1.11 (m, 1H), 0.80 (m, J = 3.6 Hz, 
1H), 0.72-0.66 (m, 1H), 0.51-0.47 (m, 1H). 
13CNMR (151MHz; CDCl3): δ 143.3, 134.8, 130.4, 129.3, 125.6, 123.4, 112.6, 111.7, 111.0, 
110.8, 79.9, 62.1, 53.4, 46.6, 45.9, 29.1, 18.0, 1.9, 0.6 
HRMS calculated for C21H17N4O [M+H]+: 341.1402, Found: 341.1403. 
 
1HNMR (400 MHz; CDCl3): δ 7.39-7.33 (m, 5H), 6.13 (d, J = 1.4 Hz, 1H), 3.71-3.66 (m, 2H), 
3.64 (d, J = 8.8 Hz, 1H), 3.50 (dd, J = 8.8, 1.8 Hz, 1H), 2.06-2.03 (m, 1H), 1.98-1.89 (m, 1H), 
1.89-1.80 (m, 1H), 1.55-1.49 (m, 3H), 1.43 (m, 2H), 1.14 (d, J = 6.2 Hz, 3H), 0.97 (t, J = 7.2 Hz, 
3H). 
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13CNMR (151 MHz; CDCl3): δ 173.1, 169.5, 144.2, 137.3, 128.9, 125.6, 124.9, 110.0, 68.2, 
52.8, 48.1, 47.5, 38.9, 38.61, 38.46, 25.2, 23.0, 21.0, 14.2. 
HRMS calculated for C21H25O4 [M+H]+: 341.1753, Found: 341.1758.  
 
1HNMR (400 MHz; CDCl3): δ  7.47 (s, 5H), 6.35 (d, J = 1.4 Hz, 1H), 3.96 (d, J = 6.6 Hz, 1H), 
3.82-3.74 (m, 1H), 2.42 (ddd, J = 15.5, 10.5, 1.4 Hz, 1H), 2.24-2.17 (m, 1H), 2.14-2.08 (m, 2H), 
1.51-1.46 (m, 4H), 1.29 (d, J = 6.2 Hz, 3H), 1.00 (t, J = 7.1 Hz, 3H). 
13CNMR (126 MHz; CDCl3): δ 144.2, 135.2, 130.5, 129.4, 125.7, 122.8, 112.7, 111.6, 111.0, 
110.6, 81.8, 69.8, 53.5, 46.5, 45.5, 38.0, 36.5, 25.1, 22.6, 20.0, 14.0 
HRMS calculated for C23H23N4O [M+H]+: 371.1872, Found: 371.1879. 
 
1HNMR (400 MHz; CDCl3): δ 7.44 (m, 2H), 7.39-7.34 (m, 3H), 6.24 (d, J = 1.5 Hz, 1H), 3.62-
3.56 (m, 2H), 3.45 (s, 1H), 3.06-3.00 (m, 1H), 1.75-1.68 (m, 2H), 1.58 (m, 2H), 1.43-1.38 (m, 
1H), 1.28-1.23 (m, 2H), 1.14 (m, J = 3.1 Hz, 2H), 0.90-0.86 (m, 2H), 0.69-0.66 (m, 1H), 0.54-
0.49 (m, 3H). 
13CNMR (101 MHz; CDCl3): δ 173.2, 169.4, 143.8, 138.0, 128.81, 128.77, 125.7, 125.4, 76.0, 
74.9, 53.4, 49.3, 48.7, 44.7, 31.88, 31.76, 25.9, 24.7, 17.3, 0.9, 0.3 
HRMS calculated for C23H25O4 [M+H]+: 365.1753, Found: 365.1759. 
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1HNMR (400 MHz; CDCl3): δ 7.55-7.52 (m, 2H), 7.48 (m, 3H), 6.38 (d, J = 1.5 Hz, 1H), 3.67 (s, 
1H), 3.12-3.06 (m, 1H), 2.13 (ddd, J = 12.4, 9.6, 2.9 Hz, 1H), 1.87-1.78 (m, 2H), 1.73-1.63 (m, 
3H), 1.46 (m, 1H), 1.29-1.25 (m, 1H), 1.19-1.15 (m, 2H), 1.06 (td, J = 12.6, 3.5 Hz, 1H), 0.86-
0.79 (m, 1H), 0.72-0.67 (m, 1H), 0.57-0.50 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 144.4, 135.6, 130.6, 129.5, 125.9, 123.4, 112.5, 111.9, 111.3, 
110.9, 79.2, 76.4, 52.30, 52.15, 46.8, 45.4, 31.9, 30.9, 25.3, 24.1, 18.6. 
HRMS calculated for C25H23N4O [M+H]+: 395.1872, Found: 395.1883. 
 
1HNMR (400 MHz; CDCl3): δ 7.29 (m, 5H), 5.73 (s, 1H), 4.16 (q, J = 7.8 Hz, 1H), 4.01 (td, J = 
8.7, 4.8 Hz, 1H), 3.70 (d, J = 9.0 Hz, 1H), 3.43 (dd, J = 9.1, 3.4 Hz, 1H), 2.89 (td, J = 8.7, 3.1 
Hz, 1H), 2.49 (m, 2H), 2.31 (m, 1H), 1.85 (m, J = 2.7 Hz, 1H), 1.61 (m, 1H), 1.52 (m, 1H), 1.41 
(m, 2H), 0.96 (t, J = 7.3 Hz, 3H). 
13CNMR (101 MHz; CDCl3): δ 179.3, 177.8, 145.3, 134.2, 128.5, 128.2, 127.0, 125.4, 84.3, 
65.6, 46.3, 44.6, 41.4, 35.2, 29.7, 29.3, 22.4, 13.9 
HRMS calculated for C20H23O4 [M+H]+: 327.1596, Found: 327.1599.  
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1HNMR (400 MHz; CDCl3): δ 7.32-7.26 (m, 5H), 5.73 (d, J = 0.8 Hz, 1H), 4.16 (m, J = 7.7 Hz, 
1H), 3.99 (td, J = 8.8, 4.8 Hz, 1H), 3.79 (dd, J = 9.2, 1.6 Hz, 1H), 3.41 (dd, J = 9.1, 3.5 Hz, 1H), 
2.88 (td, J = 8.8, 3.5 Hz, 1H), 2.54-2.48 (m, 1H), 2.32-2.25 (m, 1H), 2.02 (m, 1H), 1.87-1.77 (m, 
4H), 1.43-1.38 (m, 3H), 1.28-1.24 (m, 1H), 1.09 (qd, J = 12.3, 3.4 Hz, 1H), 0.78-0.89 (m, 1H), 
13CNMR (151 MHz; CDCl3): δ 171.0, 169.6, 141.7, 137.7, 128.6, 128.2, 126.8, 125.7, 82.0, 
66.0, 43.4, 40.97, 40.84, 40.5, 33.4, 31.50, 31.30, 26.7, 26.29, 26.16 
HRMS calculated for C22H25O4 [M+H]+: 353.1753, Found: 353.1759  
 
1HNMR (400 MHz; CDCl3): δ 7.31 (m, 5H), 5.75 (s, 1H), 4.16 (q, J = 7.8 Hz, 1H), 4.01 (m, 1H), 
3.79 (d, J = 8.9 Hz, 1H), 3.42 (dd, J = 9.1, 3.5 Hz, 1H), 3.01 (m, 1H), 2.88 (dt, J = 8.5, 4.2 Hz, 
1H), 2.29 (m, J = 4.5 Hz, 1H), 2.19 (m, 1H), 1.82-1.68 (m, 6H), 1.31 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 170.9, 169.4, 142.0, 133.9, 128.6, 128.2, 125.5, 125.2, 81.9, 
66.1, 43.4, 43.1, 40.6, 31.4, 14.8, 7.5, 6.9 
HRMS calculated for C21H23O4 [M+H]+: 339.1596, Found: 339.1589. 
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1HNMR (400 MHz; CDCl3): δ 7.30 (t, J = 5.8 Hz, 5H), 5.71 (s, 1H), 4.17 (q, J = 7.8 Hz, 1H), 
4.00 (td, J = 8.8, 4.8 Hz, 1H), 3.69-3.67 (m, 1H), 3.44 (dd, J = 9.2, 3.2 Hz, 1H), 2.90 (td, J = 9.0, 
3.1 Hz, 1H), 2.61 (dd, J = 14.6, 4.3 Hz, 1H), 2.33 (m, 1H), 2.15 (m, 1H), 1.77-1.67 (m, 7H), 1.23 
(dd, J = 17.8, 7.7 Hz, 5H). 
13CNMR (101 MHz; CDCl3): δ 171.0, 169.2, 141.7, 130.8, 130.0, 128.6, 125.6, 81.9, 65.9, 60.4, 
43.3, 42.0, 41.0, 40.4, 35.2, 33.9, 32.4, 26.1, 21.0, 14.1 
HRMS calculated for C23H27O4 [M+H]+: 367.1909, Found: 367.1914. 
 
1HNMR (400 MHz; CDCl3): δ 7.34-7.23 (m, 5H), 5.52 (s, 1H), 4.13 (q, J = 7.8 Hz, 1H), 3.95 (td, 
J = 8.7, 4.8 Hz, 1H), 3.81 (dd, J = 9.1, 1.4 Hz, 1H), 3.42 (dd, J = 9.1, 3.7 Hz, 1H), 2.87 (td, J = 
8.7, 3.6 Hz, 1H), 2.29-2.25 (m, 1H), 1.86-1.77 (m, 2H), 0.91-0.85 (m, 2H), 0.78-0.74 (m, 1H), 
0.44 (m, J = 3.4 Hz, 1H). 
13CNMR (101 MHz; CDCl3): δ 170.9, 169.4, 142.0, 133.9, 128.6, 128.2, 125.5, 125.2, 81.9, 
66.1, 43.4, 43.1, 40.6, 31.4, 14.8, 7.5, 6.9 
HRMS calculated for C19H19O4 [M+H]+: 311.1283, Found: 311.1281. 
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1HNMR (400 MHz; CDCl3): δ 7.58 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 8.2 Hz, 2H), 5.70 (s, 1H), 
4.18 (q, J = 7.8 Hz, 1H), 4.03 (dt, J = 8.8, 4.4 Hz, 1H), 3.73 (d, J = 9.0 Hz, 1H), 3.46 (dd, J = 
9.1, 3.6 Hz, 1H), 2.88 (dt, J = 8.7, 4.3 Hz, 1H), 2.49 (q, J = 7.7 Hz, 2H), 2.33 (m, 1H), 1.91-1.86 
(m, 1H), 1.64-1.59 (m, 1H), 1.52 (m, 1H), 1.40 (m, 2H), 0.97 (t, J = 7.3 Hz, 3H). 
13CNMR (126 MHz; CDCl3): δ 170.7, 168.9, 146.3, 133.0, 127.8, 126.1, 125.58, 125.55, 81.6, 
66.2, 43.1, 41.5, 40.6, 33.8, 31.7, 29.3, 22.3, 13.9 
HRMS calculated for C21H22F3O4 [M+H]+: 395.1470, Found: 395.1480. 
 
1HNMR (400 MHz; CDCl3): δ 7.35 (s, 1H), 7.24 (m, 2H), 7.06 (m, 1H), 5.68 (s, 1H), 4.15 (m, 
1H), 4.02 (m, 1H), 3.71 (d, J = 9.0 Hz, 1H), 3.44 (dd, J = 9.0, 3.4 Hz, 1H), 2.86 (td, J = 8.6, 3.2 
Hz, 1H), 2.48 (q, J = 7.6 Hz, 2H), 2.31 (m, 1H), 1.85 (m, 2H), 1.61 (m, 1H), 1.54 (m, 1H), 1.41 
(m, 2H), 0.95 (t, J = 7.2 Hz, 3H). 
13CNMR (126 MHz; CDCl3): δ 170.8, 169.0, 144.3, 136.5, 134.8, 132.8, 129.7, 128.4, 128.0, 
125.9, 123.8, 81.5, 66.2, 43.1, 41.5, 40.6, 33.8, 31.6, 29.3, 22.3, 13.9 
HRMS calculated for C20H22ClO4 [M+H]+: 361.1207, Found: 361.1203. 
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1HNMR (400 MHz; CDCl3): δ  7.19 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 Hz, 2H), 5.72 (s, 1H), 
4.17-4.11 (m, 1H), 3.97 (td, J = 8.9, 4.6 Hz, 1H), 3.78 (s, 3H), 3.69-3.67 (d, J = 9.2 Hz, 1H), 
3.44 (dd, J = 9.2, 3.2 Hz, 1H), 2.92-2.87 (m, 1H), 2.51-2.45 (m, 2H), 2.31 (, J = 4.4 Hz, 1H), 
1.86-1.77 (m, 1H), 1.60 (m, 1H), 1.53 (m, 1H), 1.42-1.37 (m, 2H), 0.96 (t, J = 7.3 Hz, 3H). 
13CNMR (126 MHz; CDCl3): δ 171.0, 169.4, 159.4, 133.5, 132.1, 128.9, 126.9, 113.9, 81.6, 
65.8, 55.2, 43.3, 41.3, 40.5, 33.8, 31.6, 29.3, 22.3, 13.9 
HRMS calculated for  C21H25O5 [M+H]+: 357.1702, Found: 357.1704. 
 
1HNMR (400 MHz; CDCl3): δ 7.16 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 Hz, 2H), 5.52 (s, 1H), 
4.09 (m, 1H), 3.90 (td, J = 8.8, 4.7 Hz, 1H), 3.82-3.80 (m, 1H), 3.79 (s, 3H), 3.44 (dd, J = 9.2, 
3.3 Hz, 1H), 2.88 (td, J = 8.9, 3.3 Hz, 1H), 2.28 (m, J = 4.4 Hz, 1H), 1.85 (m, J = 6.1 Hz, 1H), 
1.80-1.72 (m, 1H), 0.91-0.85 (m, 2H), 0.80-0.74 (m, 1H), 0.45-0.40 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 171.0, 169.5, 159.4, 133.74, 133.59, 126.9, 125.5, 113.9, 81.5, 
65.8, 55.2, 43.3, 43.0, 40.5, 31.4, 14.8, 7.5, 6.9. 
HRMS calculated for C20H21O5 [M+H]+: 341.1389, Found: 341.1393. 
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1HNMR (400 MHz; CDCl3): δ 7.12 (s, 4H), 5.51 (s, 1H), 4.10 (m, 1H), 3.93 (dt, J = 8.7, 4.4 Hz, 
1H), 3.81 (dd, J = 9.1, 1.6 Hz, 1H), 3.42 (dd, J = 9.1, 3.6 Hz, 1H), 2.86 (m, 1H), 2.27 (s, 3H), 
2.26 (m, 1H), 1.85-1.76 (m, 2H), 0.90-0.84 (m, 2H), 0.77-0.74 (m, 1H), 0.43 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 170.9, 169.5, 142.6, 131.1, 128.6, 128.2, 126.8, 125.6, 81.8, 
75.0, 44.9, 42.9, 40.2, 22.8, 14.5, 7.2, 6.7, 6.0 
HRMS calculated for C20H21O4 [M+H]+: 325.1440, Found: 325.1437. 
 
1HNMR (400 MHz; CDCl3): δ  7.24-7.19 (m, 5H), 5.41 (s, 1H), 4.09 (m, 1H), 3.90 (dt, J = 8.9, 
4.5 Hz, 1H), 3.56 (d, J = 8.5 Hz, 1H), 3.14 (m, 1H), 2.94 (m, 1H), 2.71 (s, 3H), 2.24 (m, J = 3.9 
Hz, 1H), 1.79-1.72 (m, 1H), 0.88-0.85 (m, 2H), 0.81 (m, 1H), 0.37-0.34 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 177.0, 175.9, 142.0, 136.5, 127.9, 125.8, 123.61, 123.51, 82.1, 
66.0, 44.4, 42.5, 39.3, 31.9, 24.5, 15.4, 7.9, 6.1 
HRMS calculated for C20H22NO3 [M+H]+: 324.1600, Found: 324.1598. 
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1HNMR (500 MHz; CDCl3): δ  7.24-7.18 (m, 5H), 5.67 (s, 1H), 4.53 (m, 1H), 3.40 (d, J = 8.5 
Hz, 1H), 3.18-3.13 (m, 1H), 3.09 (d, J = 8.5 Hz, 1H), 2.68 (s, 3H), 2.59-2.57 (m, 1H), 2.52 (m, 
1H), 2.31 (m, 1H), 1.60-1.57 (m, 2H), 1.47-1.41 (m, 2H), 1.32 (d, J = 6.1 Hz, 3H), 0.98 (t, J = 
7.3 Hz, 3H). 
13CNMR (126 MHz; cdcl3): δ 177.3, 175.9, 143.0, 132.1, 128.8, 128.0, 127.8, 125.9, 82.4, 75.4, 
46.3, 40.84, 40.74, 39.1, 34.3, 29.4, 24.7, 23.0, 22.4, 14.0 
HRMS calculated for C22H27NO3 [M+H]+: 354.2069, Found: 354.2064. 
 
1HNMR (400 MHz; CDCl3): δ 7.32-7.27 (m, 3H), 7.25-7.23 (m, 2H), 5.57 (s, 1H), 4.54-4.45 (m, 
1H), 3.77 (d, J = 9.1 Hz, 1H), 3.44-3.40 (m, 1H), 3.11-3.06 (m, 1H), 2.33 (m, 1H), 1.91-1.84 (m, 
1H), 1.47-1.41 (m, 1H), 1.27 (d, J = 6.0 Hz, 3H), 0.91-0.85 (m, 2H), 0.81-0.76 (m, 1H), 0.45-
0.39 (m, 1H). 
13CNMR (101 MHz; CDCl3): δ 170.9, 169.5, 142.6, 131.1, 128.6, 128.2, 126.8, 125.6, 81.8, 
75.0, 44.9, 42.9, 40.2, 22.8, 14.5, 7.2, 6.7, 6.0 
HRMS calculated for C20H21O4 [M+H]+: 325.1440, Found: 325.1443. 
 
1HNMR (400 MHz; CDCl3): δ 7.26-7.21 (m, 3H), 7.15-7.13 (m, 2H), 5.42 (s, 1H), 3.72 (td, J = 
10.1, 3.6 Hz, 1H), 3.52 (d, J = 8.4 Hz, 1H), 3.07 (d, J = 8.5 Hz, 1H), 2.81 (s, 3H), 2.74 (d, J = 
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12.0 Hz, 1H), 2.21-2.19 (m, 1H), 2.02-1.95 (m, 1H), 1.86 (m, 1H), 1.82-1.80 (m, 1H), 1.31-1.26 
(m, 4H), 1.19 (m, 2H), 0.84 (m, 2H), 0.76 (m, 1H), 0.36 (m, J = 3.1 Hz, 1H). 
13CNMR (101 MHz; cdcl3): δ 177.7, 176.2, 144.6, 132.0, 128.2, 125.5, 125.03, 124.92, 84.5, 
82.4, 49.4, 42.63, 42.53, 37.3, 32.2, 27.1, 25.3, 24.9, 24.1, 14.9, 7.7, 6.3 
HRMS calculated for C24H28NO3 [M+H]+: 378.2069, Found: 378.2071. 
 
1HNMR (500 MHz; CDCl3): δ 7.32-7.29 (m, 2H), 7.25 (m, 1H), 7.21-7.19 (m, 2H), 5.54 (s, 1H), 
3.75 (dd, J = 9.3, 1.9 Hz, 1H), 3.71 (m, 1H), 3.42 (dd, J = 9.2, 1.6 Hz, 1H), 2.72-2.69 (m, 1H), 
2.22 (m, 1H), 1.88 (m, 2H), 1.81 (m, J = 3.0 Hz, 2H), 1.33 (m, 1H), 1.30-1.25 (m, 2H), 1.19 (m, 
2H), 0.89-0.84 (m, 2H), 0.73-0.68 (m, 1H), 0.46 (m, J = 3.3 Hz, 1H). 
13CNMR (126 MHz; CDCl3): δ 171.6, 169.3, 144.2, 129.4, 128.6, 127.9, 126.3, 125.2, 84.1, 
81.5, 49.5, 48.2, 42.8, 38.4, 32.0, 27.1, 25.2, 24.0, 14.2, 7.3, 7.0 
HRMS calculated for C23H25O4 [M+H]+: 365.1753, Found: 365.1755. 
Supporting information of the alkynylation reaction  
General procedure for synthesizing compounds 27. !
 
Figure 57. General reaction for alkynylation reaction !
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Ph
Ph
O (ArO)3PAu(TA-Ph)OTf 3%+ O
Ph
HCHCl3 (0.75 M), rt, 6h
24a 25a 27a
! 80!
To a 2 ml vial, gold catalyst (0.03 mmol) was added to a solution of 22a (2 mmol) in 0.75 
ml chloroform. The reaction mixture stirred and then 24a (1 mmol) in 0.75 ml of chloroform was 
added slowly using a syringe pump during 3 hours to the mixture.  The resulting mixture stirred 
at room temperature for additional 3 hours. After that, the mixture was loaded on column 
chromatography on silica gel for purification by hexane/ethyl acetate (20:1) to obtain the desired 
product. 
General procedure for synthesizing compounds 29. !
 
Figure 58. General scheme for alkynylation of glycals !
The gold catalyst (0.3 mmol) was added to a solution of alkyne (2 mmol) in 1.5 ml of 
chloroform. Then the glycal 28a (1mmol) was added to the mixture. The resulting mixture stirred 
at 70 oC for 4 hours. The reaction mixture was loaded on column chromatography on silica gel 
for separation by hexane/ethyl acetate (5:1) to get the desired product. 
Procedure for synthesis of triarylphosphitegoldacetalyde ! !!!!
 
O
+ Ph O
Ph
28a 29aOAc
AcO
AcO
AcO
OAc(ArO)3PAu(TA-Ph)OTf 3%
DCE (0.75 M), 70 oC, 4h
(ArO)3PAuCl
1.1 eq AgOAc
DCM (0.1 M), 4h, rt
(ArO)3PAuOAc
1.5 eq Ph
DCM, 30 min, rt
(ArO)3PAu Ph
tBu
tBuAr =
! 81!
Figure 59. General reaction for the synthesis gold-acetalyde complex.  !
A screw-cap vial was charged with (ArO)3PAuCl (1 mmol) in 10 ml dry 
dichloromethane, followed by the addition of AgOAc (1.1 mmol). The vial was stirred at room 
temperature for approximately 5 hours. Then the reaction mixture was slowly filtered through a 
pad of celite into a separate vial. The celite pad rinsed with 20 ml more dichloromethane into the 
vial. The combined filtrate was concentrated in roto vap to give the solid product 
(ArO)3PAuOAc. To the compound (ArO)3PAuOAc, was added 20 ml of dry dichloromethane 
followed by addition of phenylacetylene (1.5 mmol) and stirred for 30 minutes. The reaction 
mixture was then slowly filtered through a pad of celite. The resulting solution was concentrated 
on roto vap to remove the dichloromethane, acetic acid side product and the excess 
phenylacetylene. The resulting colorless oil (ArO)3PAuCCPh was directly used for the reactions.  
Compound characterization data for alkynylation reaction 
 
1HNMR (400 MHz; CDCl3): δ  7.45 (m, J = 6.7, 3.0 Hz, 2H), 7.29 (m, J = 4.5, 2.1 Hz, 3H), 4.51 
(dd, J = 7.8, 2.9 Hz, 1H), 4.07-4.03 (m, 1H), 3.59 (ddd, J = 11.7, 8.4, 3.3 Hz, 1H), 1.95-1.90 (m, 
2H), 1.82-1.78 (m, 1H), 1.64-1.58 (m, 3H). 
13CNMR (126 MHz; CDCl3): δ 131.7, 128.24, 128.17, 122.7, 88.1, 85.2, 67.4, 66.6, 32.2, 25.7, 
21.8 
HRMS calculated for C13H15O [M+H]+: 187.1045, Found: 187.1041 
O
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1HNMR (500 MHz; CDCl3): δ  7.44-7.43 (m, 1H), 7.34-7.28 (m, 2H), 7.24-7.21 (m, 1H), 4.50 
(dd, J = 7.9, 2.9 Hz, 1H), 4.05-4.03 (m, 1H), 3.61-3.57 (m, 1H), 1.94-1.89 (m, 2H), 1.80-1.75 
(m, 1H), 1.64-1.59 (m, 3H). 
13CNMR (126 MHz; CDCl3) δ 134.0, 131.6, 129.9, 129.4, 128.6, 124.4, 89.4, 83.8, 77.3, 67.3, 
66.7, 32.0, 25.6, 21.8 
HRMS calculated for C13H14ClO [M+H]+: 221.0655, Found: 221.0659 
 
1HNMR (400 MHz; CDCl3): δ  7.27-7.23 (m, 2H), 7.15-7.13 (m, 1H), 7.04-6.99 (m, 1H), 4.50 
(dd, J = 7.9, 2.7 Hz, 1H), 4.06-4.01 (m, 1H), 3.62-3.56 (m, 1H), 1.94-1.89 (m, 2H), 1.82-1.75 
(m, 1H), 1.64-1.57 (m, 3H). 
13CNMR (126 MHz; CDCl3) δ 162.3 (JC-F = 1224.5 Hz), 129.77(JC-F = 43.5 Hz), 127.62 (JC-F = 
16.5 Hz), 124.58 (JC-F = 47.5 Hz), 118.6 (JC-F = 113.5 Hz), 115.6 (JC-F = 105.5 Hz), 89.1, 83.94 
(jC-F = 18 Hz), 67.3, 66.7, 32.0, 25.6, 21.8 
HRMS calculated for C13H14FO [M+H]+: 205.0950, Found: 205.0951 
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1HNMR (500 MHz; CDCl3): δ  7.38 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.7 Hz, 2H), 4.50 (dd, J = 
7.8, 2.9 Hz, 1H), 4.05 (m, J = 3.4 Hz, 1H), 3.60-3.56 (m, 1H), 1.93-1.89 (m, 2H), 1.81-1.77 (m, 
1H), 1.63-1.57 (m, 3H), 1.30 (s, 9H). 
13CNMR (126 MHz; CDCl3)δ 151.5, 131.4, 125.2, 119.7, 87.4, 85.3, 67.5, 66.6, 34.7, 32.2, 31.1, 
25.7, 21.8 
HRMS calculated for C17H23O [M+H]+: 243.1671, Found: 243.1668. 
 
1HNMR (400 MHz; CDCl3): δ  7.38 (d, J = 8.9 Hz, 2H), 6.82 (d, J = 8.9 Hz, 2H), 4.48 (dd, J = 
8.0, 2.9 Hz, 1H), 4.07-4.02 (m, 1H), 3.80 (s, 3H), 3.60-3.55 (m, 1H), 1.93-1.88 (m, 2H), 1.80-
1.74 (m, 1H), 1.63-1.56 (m, 3H). 
13CNMR (126 MHz; CDCl3) δ 159.5, 133.2, 114.8, 113.8, 86.7, 85.0, 67.5, 66.6, 55.2, 32.3, 25.7, 
21.9 
HRMS calculated for C14H17O2 [M+H]+: 217.1150, Found: 217.1153 
 
1HNMR (500 MHz; CDCl3): δ  4.19 (dd, J = 6.2, 4.3 Hz, 1H), 3.96 (dt, J = 11.7, 3.8 Hz, 1H), 
3.49-3.45 (m, 1H), 1.80 (m, J = 3.0 Hz, 2H), 1.62-1.49 (m, 4H), 1.27-1.24 (m, 1H), 0.75 (m, 
2H), 0.68 (m, 2H). 
13CNMR (126 MHz; CDCl3) δ 88.8, 74.4, 67.4, 66.7, 32.5, 25.6, 22.0, 8.2, -0.6 
HRMS calculated for C10H15O [M+H]+: 151.1045, Found: 151.1049 
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1HNMR (500 MHz; CDCl3): δ  4.22 (m, 1H), 3.97 (dt, J = 11.4, 3.8 Hz, 1H), 3.50-3.46 (m, 1H), 
2.66-2.60 (m, 1H), 1.90 (m, 2H), 1.84-1.78 (m, 2H), 1.69 (m, 2H), 1.63-1.51 (m, 9H). 
13CNMR (126 MHz; CDCl3) δ 90.0, 78.6, 67.4, 66.7, 33.8, 32.6, 30.1, 25.7, 24.9, 22.0 
HRMS calculated for C12H19O [M+H]+: 179.1358, Found: 179.1361 
 
1HNMR (400 MHz; CDCl3): δ 6.06 (m, 1H), 4.33 (dd, J = 7.8, 2.7 Hz, 1H), 3.96-3.91 (m, 1H), 
3.49 (m, 1H), 2.09-2.02 (m, 4H), 1.82-1.77 (m, 2H), 1.62-1.50 (m, 8H). 
13CNMR (126 MHz; CDCl3) δ 135.0, 120.1, 87.0, 85.3, 67.4, 66.4, 32.3, 29.1, 25.63, 25.57, 
25.54, 22.2, 21.8, 21.4 
HRMS calculated for C13H19O [M+H]+: 191.1358, Found: 191.1357 
 
1HNMR (500 MHz; CDCl3): δ 7.58 (s, 1H), 7.43 (d, J = 1.6 Hz, 1H), 7.41 (d, J = 1.6 Hz, 1H), 
7.26 (s, 1H), 4.50 (dd, J = 7.8, 2.9 Hz, 1H), 4.05-4.03 (m, 1H), 3.61-3.57 (m, 1H), 3.07 (s, 1H), 
1.93-1.89 (m, 2H), 1.80-1.77 (m, 1H), 1.64-1.58 (m, 3H). 
13CNMR (126 MHz; CDCl3) δ 135.3, 132.00, 131.84, 128.3, 123.1, 122.3, 88.9, 84.2, 82.7, 77.7, 
67.3, 66.6, 32.1, 25.6, 21.8 
HRMS calculated for C15H14O [M+H]+: 210.1045, Found: 210.1048  
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1HNMR (400 MHz; CDCl3): δ 7.44 (d, J = 2.8 Hz, 1H), 7.26-7.23 (m, 1H), 7.11 (d, J = 5.0 Hz, 
1H), 4.48 (dd, J = 7.9, 2.5 Hz, 1H), 4.04 (dt, J = 11.4, 4.1 Hz, 1H), 3.57 (td, J = 10.0, 3.2 Hz, 
1H), 1.94-1.89 (m, 2H), 1.81-1.74 (m, 1H), 1.60 (m, 3H). 
13CNMR (126 MHz; CDCl3) δ 129.9, 128.9, 125.1, 121.7, 87.7, 80.2, 67.5, 66.7, 32.1, 25.6, 21.8 
HRMS calculated for C11H13OS [M+H]+: 193.0609, Found: 193.0611 
 
1HNMR (400 MHz; CDCl3): δ 7.45-7.43 (m, 2H), 7.30 (m, 3H), 4.19 (t, J = 6.5 Hz, 1H), 3.89-
3.85 (m, 1H), 3.53-3.49 (m, 1H), 1.87-1.80 (m, 2H), 1.26 (d, J = 14.1 Hz, 3H), 1.07 (d, J = 14.9 
Hz, 3H). 
13CNMR (126 MHz; CDCl3) δ 131.7, 128.21, 128.16, 122.9, 88.6, 85.4, 71.2, 64.3, 29.0, 15.2, 
9.8 
HRMS calculated for C13H17O [M+H]+: 189.1201, Found: 189.1188. 
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1HNMR (500 MHz; CDCl3): δ 7.42 (s, 1H), 7.30-7.23 (m, 3H), 4.17 (t, J = 6.5 Hz, 1H), 3.87-
3.81 (dq, J = 9.2, 7.0 Hz, 1H), 3.50 (dq, J = 9.2, 7.0 Hz, 1H), 1.81 (m, 2H), 1.25 (t, J = 7.0 Hz, 
3H), 1.05 (t, J = 7.4 Hz, 3H). 
13CNMR (126 MHz; CDCl3) δ 134.0, 131.6, 129.8, 129.4, 128.5, 124.6, 90.0, 84.0, 71.1, 64.4, 
28.9, 15.2, 9.8 
 
1HNMR (500 MHz; CDCl3): δ 7.39-7.37 (m, 2H), 7.33-7.31 (m, 2H), 4.18 (t, J = 6.5 Hz, 1H), 
3.86 (dq, J = 9.2, 7.0 Hz, 1H), 3.50 (dq, J = 9.2, 7.0 Hz, 1H), 1.85-1.78 (m, 2H), 1.30 (s, 9H), 
1.25 (t, J = 14.1 Hz, 3H), 1.06 (t, J = 14.9 Hz, 3H). 
13CNMR (126 MHz; CDCl3) δ 151.4, 131.4, 125.2, 119.9, 87.9, 85.5, 71.2, 64.2, 34.7, 31.2, 29.1, 
15.2, 9.8 
HRMS calculated for C17H25O [M+H]+: 245.1827, Found: 245.1881. 
 
1HNMR (500 MHz; CDCl3): δ 7.43 (m, 2H), 7.29 (m, 3H), 4.82 (dd, J = 7.2, 5.0 Hz, 1H), 4.01 
(m, 1H), 3.86 (m, 1H), 2.25-2.20 (m, 1H), 2.11-2.06 (m, 2H), 1.95 (m, J = 2.7 Hz, 1H). 
13CNMR (126 MHz; CDCl3) δ 131.7, 128.22, 128.18, 122.8, 89.0, 84.4, 68.6, 67.9, 33.4, 25.5 
HRMS calculated for C12H13O [M+H]+: 173.0888, Found: 173.0892 
O
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1HNMR (500 MHz; CDCl3): δ 7.26-7.20 (m, 2H), 7.13 (m, 1H), 7.01 (m, 1H), 4.82-4.79 (m, 
1H), 4.01 (m, 1H), 3.87 (m, 1H), 2.27-2.21 (m, 1H), 2.13-2.06 (m, 2H), 1.99-1.93 (m, 1H). 
13CNMR (126 MHz; CDCl3) δ 162.2 (JC-F = 980.5 Hz), 129.77 (JC-F = 34.5 Hz), 127.58 (JC-F = 
12.5 Hz), 124.64 (JC-F = 38 Hz), 118.50 (JC-F = 90.5 Hz), 115.61 (JC-F = 84.5 Hz), 90.1, 83.23 
(JC-F = 16.5 Hz), 68.5, 68.0, 33.3, 25.5 
HRMS calculated for C12H12FO [M+H]+: 191.0794, Found: 191.0798  
 
1HNMR (500 MHz; CDCl3): δ 7.46-7.44 (m, 2H), 7.31-7.30 (m, 3H), 3.44 (s, 3H), 2.01 (m, 2H), 
1.71 (m, 2H), 1.67-1.54 (m, 6H). 
13CNMR (126 MHz; CDCl3) δ 131.7, 128.20, 128.09, 123.0, 90.3, 86.1, 74.4, 50.8, 36.8, 25.5, 
22.9 
HRMS calculated for C15H19O [M+H]+: 215.1358, Found: 215.1358 
 
1HNMR (400 MHz; CDCl3): δ 7.38-7.36 (m, 2H), 7.32-7.30 (m, 2H), 3.41 (s, 3H), 2.00-1.97 (m, 
2H), 1.70-1.53 (m, 8H), 1.29 (s, 9H). 
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13CNMR (126 MHz; CDCl3) δ 151.4, 131.4, 125.2, 120.0, 89.5, 86.2, 74.4, 50.7, 36.9, 34.7, 31.2, 
25.5, 22.9 
HRMS calculated for C19H27O [M+H]+: 271.1984, Found: 271.1985 
 
1HNMR (500 MHz; CDCl3): δ 7.46-7.44 (m, 2H), 7.35-7.32 (m, 3H), 5.99 (ddd, J = 10.2, 3.5, 
1.9 Hz, 1H), 5.83 (dt, J = 10.2, 1.9 Hz, 1H), 5.36-5.33 (dq, J = 3.6, 1.9 Hz, 1H), 5.21 (m, 1H), 
4.27 (d, J = 3.9 Hz, 2H), 4.20 (dt, J = 8.6, 4.2 Hz, 1H), 2.10 (s, J = 0.5 Hz, 6H). 
13CNMR (126 MHz; CDCl3) δ 170.9, 170.3, 131.8, 129.2, 128.7, 128.3, 125.5, 122.2, 86.7, 84.7, 
70.0, 64.8, 64.5, 63.1, 21.03, 20.83 
HRMS calculated for C18H19O5 [M+H]+: 315.1154, Found: 315.1157 
 
1HNMR (400 MHz; CDCl3): δ 7.39 (d, J = 8.6 Hz, 2H), 7.34 (d, J = 8.5 Hz, 2H), 5.98 (ddd, J = 
10.1, 3.6, 1.9 Hz, 1H), 5.81 (dt, J = 10.2, 1.9 Hz, 1H), 5.34 (dq, J = 8.9, 2.0 Hz, 1H), 5.19 (dt, J = 
3.5, 1.8 Hz, 1H), 4.26 (d, J = 3.9 Hz, 2H), 4.20 (dt, J = 8.6, 4.1 Hz, 1H), 2.10 (s, 6H), 1.31 (s, 
9H). 
13CNMR (126 MHz; CDCl3) δ 170.9, 170.3, 152.1, 131.6, 129.4, 125.41, 125.31, 119.1, 86.8, 
84.0, 69.9, 64.8, 64.5, 63.1, 34.8, 21.02, 20.83 
HRMS calculated for C22H27O5 [M+H]+: 371.1780, Found: 371.1781 
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1HNMR (400 MHz; CDCl3): δ 7.44 (t, J = 1.8 Hz, 1H), 7.34-7.31 (m, 2H), 7.27 (m, 1H), 5.97 
(ddd, J = 10.2, 3.5, 1.9 Hz, 1H), 5.84 (dt, J = 10.2, 1.9 Hz, 1H), 5.34 (dq, J = 8.9, 2.0 Hz, 1H), 
5.19 (dt, J = 3.6, 1.8 Hz, 1H), 4.27 (d, J = 3.9 Hz, 2H), 4.17 (dt, J = 8.6, 4.2 Hz, 1H), 2.11 (s, 
6H). 
13CNMR (126 MHz; CDCl3) δ 170.7, 170.2, 134.1, 131.6, 129.8, 129.5, 129.0, 128.7, 125.7, 
123.8, 85.9, 85.1, 70.1, 64.6, 64.2, 62.9, 20.93, 20.73 
HRMS calculated for C18H18O5 [M+H]+: 349.0765, Found: 349.0771 
 
1HNMR (400 MHz; CDCl3): δ 7.46-7.41 (m, 2H), 7.05-7.00 (m, 2H), 5.97 (ddd, J = 10.2, 3.5, 
1.9 Hz, 1H), 5.83 (dt, J = 10.2, 1.9 Hz, 1H), 5.34 (dq, J = 8.9, 2.0 Hz, 1H), 5.19 (dt, J = 3.6, 1.8 
Hz, 1H), 4.27 (d, J = 3.9 Hz, 2H), 4.18 (dt, J = 8.6, 4.2 Hz, 1H), 2.10 (s, 6H). 
13CNMR (126 MHz; CDCl3) δ 170.8, 170.2, 162.7 (JC-F = 996 Hz), 133.75 (JC-F = 16.5 Hz), 
129.0, 125.5, 118.20 (JC-F = 13.5 Hz), 115.60 (JC-F = 87.5 Hz), 85.5, 84.40 (JC-F = 5.5 Hz), 70.0, 
64.7, 64.3, 63.0, 20.97, 20.77 
HRMS calculated for C18H18FO5 [M+H]+: 333.1060, Found: 333.1067 
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1HNMR (500 MHz; CDCl3): δ 7.46 (d, J = 8.6 Hz, 2H), 7.31 (d, J = 8.6 Hz, 2H), 5.97 (ddd, J = 
10.2, 3.5, 1.9 Hz, 1H), 5.84 (dt, J = 10.2, 2.0 Hz, 1H), 5.34 (dq, J = 8.9, 2.0 Hz, 1H), 5.19 (dt, J = 
3.6, 1.9 Hz, 1H), 4.27 (d, J = 4.4 Hz, 2H), 4.17 (dt, J = 8.7, 4.2 Hz, 1H), 2.10 (s, 6H). 
13CNMR (126 MHz; CDCl3) δ 170.7, 170.2, 133.2, 131.5, 128.8, 125.6, 123.0, 121.0, 85.8, 85.5, 
70.0, 64.6, 64.3, 62.9, 20.93, 20.73 
HRMS calculated for C18H18BrO5 [M+H]+: 394.0259, Found: 394.0265 
 
1HNMR (500 MHz; CDCl3): δ 10.02 (s, 1H), 7.86-7.85 (m, 2H), 7.62-7.60 (m, 2H), 6.00 (ddd, J 
= 10.3, 3.1, 2.0 Hz, 1H), 5.87 (m, 1H), 5.36 (m, 1H), 5.24 (m, 1H), 4.29-4.28 (m, 2H), 4.20 (m, 
1H), 2.11 (s, 6H). 
13CNMR (126 MHz; CDCl3) δ 191.1, 170.5, 170.0, 135.6, 132.1, 130.3, 129.2, 128.3, 125.7, 
88.5, 85.4, 
70.0, 64.4, 64.0, 62.7, 20.72, 20.53  
HRMS calculated for C19H19O6 [M+H]+: 343.1103, Found: 343.1105 
 
1HNMR (400 MHz; CDCl3): δ 7.47-7.45 (m, 2H), 7.32 (m, 3H), 5.96 (d, J = 10.0 Hz, 1H), 5.80 
(d, J = 10.1 Hz, 1H), 5.13 (m, 1H), 5.08 (d, J = 8.1 Hz, 1H), 4.08 (quintet, J = 6.5 Hz, 1H), 2.10 
(s, 3H), 1.29 (d, J = 6.1 Hz, 3H). 
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13CNMR (126 MHz; CDCl3) δ 170.5, 131.8, 128.2, 125.6, 124.8, 122.3, 102.1, 86.0, 85.5, 70.3, 
68.2, 63.8, 21.1, 18.1 
HRMS calculated for C16H17O3 [M+H]+: 257.1099, Found: 257.1102 
 
1HNMR (400 MHz; CDCl3): δ 7.45-7.42 (m, 2H), 7.03-6.99 (m, 2H), 5.96-5.93 (m, 1H), 5.80 
(dt, J = 10.1, 2.0 Hz, 1H), 5.12 (dt, J = 3.5, 1.8 Hz, 1H), 5.07 (dq, J = 8.2, 2.0 Hz, 1H), 4.06 (dq, 
J = 8.1, 6.3 Hz, 1H), 2.10 (s, 3H), 1.29 (d, J = 6.3 Hz, 3H). 
13CNMR (126 MHz; CDCl3) δ 170.5, 162.6 (JC-F = 994 Hz), 133.87 (JC-F = 3.5 Hz), 129.2, 
125.7, 118.43 (JC-F = 14 Hz), 115.55 (JC-F = 88 Hz), 85.2, 84.9, 70.2, 68.2, 63.7, 21.1, 18.1 
HRMS calculated for C16H16FO3 [M+H]+: 275.1005, Found: 275.1010 
 
1HNMR (400 MHz; CDCl3): δ 7.34-7.26 (m, 14H), 6.00 (dt, J = 10.2, 1.8 Hz, 1H), 5.87 (ddd, J = 
10.2, 3.5, 1.8 Hz, 1H), 5.16 (m, 1H), 4.64-4.53 (m, 4H), 4.20 (dq, J = 8.9, 1.9 Hz, 1H), 4.03 (dt, 
J = 8.9, 3.1 Hz, 1H), 3.77 (d, J = 3.2 Hz, 2H). 
13CNMR (126 MHz; CDCl3) δ 138.06, 137.88, 134.0, 131.7, 129.9, 129.4, 128.7, 128.38, 128.31, 
127.9, 127.6, 127.33, 127.25, 124.1, 93.9, 87.0, 84.6, 73.4, 72.4, 71.4, 69.8, 68.9, 64.4 
HRMS calculated for C28H26ClO3 [M+H]+: 445.1492, Found: 445.1492 
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1HNMR (400 MHz; CDCl3): δ 7.46-7.43 (m, 2H), 7.31 (m, 3H), 5.96 (m, J = 1.6 Hz, 1H), 5.83 
(dq, J = 10.1, 1.8 Hz, 1H), 5.35-5.31 (m, 1H), 5.18 (m, 1H), 4.06-4.01 (m, 1H), 3.86-3.79 (m, 
2H), 2.08 (s, 3H), 0.90 (s, 9H), 0.09 (m, 3H), 0.07 (m, 3H). 
13CNMR (126 MHz; CDCl3) δ 170.3, 131.8, 129.3, 128.5, 128.2, 125.7, 122.4, 86.2, 85.3, 72.8, 
65.1, 64.2, 63.1, 60.4, 25.98, 25.82, 21.1, 18.4, 14.2 
HRMS calculated for C22H31O4Si [M+H]+: 387.1913, Found: 387.1915 
 
1HNMR (500 MHz; CDCl3): δ 7.43 (t, J = 1.7 Hz, 1H), 7.31 (m, J = 1.5 Hz, 2H), 7.24 (m, 1H), 
5.94 (ddd, J = 10.1, 3.5, 1.8 Hz, 1H), 5.84 (dt, J = 10.1, 1.9 Hz, 1H), 5.32 (dq, J = 8.7, 2.0 Hz, 
1H), 5.17 (dt, J = 3.5, 1.8 Hz, 1H), 4.00 (ddd, J = 8.4, 5.5, 2.7 Hz, 1H), 3.85-3.76 (m, 2H), 2.09 
(s, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 
13CNMR (126 MHz; CDCl3) δ 170.3, 134.1, 131.7, 129.9, 129.5, 128.93, 128.84, 126.0, 124.1, 
86.7, 84.8, 73.0, 65.0, 64.1, 63.0, 25.9, 21.1, 18.4, -0.0, -5.3 
HRMS calculated for C22H30ClO4Si [M+H]+: 421.1524, Found: 421.1530 
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1HNMR (500 MHz; CDCl3): δ 10.01 (s, 1H), 8.07 (d, J = 8.2 Hz, 2H), 7.82-7.81 (m, 2H), 7.55 
(m, 3H), 7.42 (m, 2H), 6.00 (ddd, J = 10.2, 3.5, 1.8 Hz, 1H), 5.90 (dt, J = 10.2, 1.9 Hz, 1H), 5.45 
(dq, J = 6.9, 2.1 Hz, 1H), 5.25 (m, 1H), 4.60 (dd, J = 12.0, 2.6 Hz, 1H), 4.46 (dd, J = 12.0, 5.9 
Hz, 1H), 4.34 (ddd, J = 8.8, 6.0, 2.7 Hz, 1H), 2.10 (s, 3H). 
13CNMR (126 MHz; CDCl3) δ 191.3, 170.3, 166.3, 135.7, 133.1, 132.2, 129.7, 129.4, 128.5, 
128.3, 126.1, 88.8, 85.5, 70.5, 65.0, 64.3, 63.5, 21.0 
HRMS calculated for C24H21O6 [M+H]+: 405.1260, Found: 405.1263 
 
1HNMR (500 MHz; CDCl3): δ 7.24-7.20 (m, 3H), 5.99-5.96 (m, 1H), 5.82 (dt, J = 10.2, 1.9 Hz, 
1H), 5.34 (dq, J = 9.0, 2.0 Hz, 1H), 5.19 (dt, J = 3.6, 1.8 Hz, 1H), 4.26 (d, J = 3.9 Hz, 2H), 4.21-
4.17 (m, 1H), 2.89 (m, 2H), 2.51 (dd, J = 18.9, 8.6 Hz, 1H), 2.42-2.38 (m, 1H), 2.29 (m, 1H), 
2.14-2.01 (m, 11H), 1.63-1.44 (m, 6H), 0.91 (s, 3H). 
13CNMR (126 MHz; CDCl3) δ 220.5, 170.8, 170.2, 140.7, 136.6, 132.2, 129.27, 129.08, 125.32, 
125.31, 119.4, 86.7, 84.0, 69.9, 64.8, 64.4, 63.0, 50.4, 47.8, 44.4, 37.9, 35.7, 31.5, 29.0, 26.2, 
25.5, 21.5, 20.97, 20.78, 13.8 
HRMS calculated for C30H35O6 [M+H]+: 491.2355, Found: 491.2361 
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1HNMR (400 MHz; CDCl3): δ 7.49-7.41 (m, 8H), 7.32-7.30 (m, 1H), 7.20-7.12 (m, 5H), 1.45 (s, 
27H), 1.29 (s, 27H). 
13CNMR (126 MHz; CDCl3) δ 147.6, 147.4, 139.0, 132.3, 132.1, 128.7, 128.3, 127.9, 127.0, 
125.1, 124.1, 119.3, 35.0, 34.6, 31.4, 30.5 
31PNMR (162 MHz; cdcl3): δ 131.0 
HRMS calculated for C50H69AuO3P [M+H]+: 945.4572, Found: 945.4579 
Supporting information of cyclopropanol ring opening  !
Procedure for synthesizing compounds 31. 
 
The cyclopropanols synthesized by modified Kulinkovich cyclopropanation methods 
previously reported on:  
Jiao, J.; Nguyen, L. X.; Patterson, D. R.; Flowers II, R. A. Org. Lett. 2007, 9, 1323-1327. 
Ye, Z.; Dai, M.; Org. Lett. 2015, 17, 2190–2193. 
Procedure for synthesizing compounds 33. 
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Figure 60. General reaction for synthesis the ketone synthesis 
 
In a 2 ml vial, to a solution of cyclopropanol (1 mmol) in 2.5 ml acetonitrile (0.4 M), gold 
catalyst (0.1 mmol), diazonium salt (2 mmol) and lithium carbonate (10 mmol) was added 
respectively. The resulting mixture allowed to stir at 50 oC for 6 hours. After that, the reaction 
mixture was directly loaded on column chromatography on silica gel for purification by 
hexane/ethyl acetate (20:1) as solvent to isolate the desired product. 
Compound characterization of compounds 33.  !
 
1HNMR (500 MHz; CDCl3): δ 7.11 (d, J = 7.8 Hz, 2H), 7.05 (m, 4H), 6.92 (m, 2H), 3.61 (s, 2H), 
2.82 (t, J = 7.4 Hz, 2H), 2.74-2.71 (t, J = 7.4 Hz, 2H), 2.33 (s, 3H). 
13CNMR (126 MHz; CDCl3): δ 207.5, 161.31 (JC-F= 244.31 Hz), 136.70, 136.54 (JC-F = 3.27 
Hz),130.8, 129.69 (JC-F = 7.68 Hz), 129.4, 129.2, 115.123 (JC-F = 21.168 Hz), 77.3, 77.0, 76.7, 
50.0, 43.29 (JC-F= 0.75 Hz), 28.9, 21.1 
HRMS calculated for C17H17FNaO+ [M+Na]+: 279.1356, Found: 279.1348. 
 
1HNMR (500 MHz; CDCl3): δ 7.21-7.18 (m, 2H), 7.11 (d, J = 7.9 Hz, 2H), 7.04-7.02 (m, 4H), 
3.61 (s, 2H), 2.82 (t, J = 7.4 Hz, 2H), 2.72 (t, J = 7.2 Hz, 2H), 2.33 (s, 3H). 
13CNMR (126 MHz; CDCl3): δ 207.3, 139.4, 136.7, 131.8, 130.8, 129.7, 129.2, 128.5, 119.1, 
77.3, 77.0, 76.7, 50.0, 43.0, 29.0, 21.1 
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HRMS calculated for C17H17ClNaO+ [M+Na]+: 295.0860, Found: 295.0873. 
 
1HNMR (400 MHz; CDCl3): δ 7.84 (d, J = 8.2 Hz, 2H), 7.20 (d, J = 8.2 Hz, 2H), 7.11 (d, J = 7.9 
Hz, 2H), 7.04 (d, J = 7.9 Hz, 2H), 3.62 (s, 2H), 2.91 (t, J = 7.4 Hz, 2H), 2.77 (t, J = 7.4 Hz, 2H), 
2.57 (s, 3H), 2.32 (s, 3H). 
13CNMR (126 MHz; CDCl3): δ 207.1, 197.7, 146.7, 136.7, 135.2, 130.8, 129.4, 129.2, 128.54, 
128.53, 77.3, 77.0, 76.7, 50.0, 42.6, 29.6, 26.5, 21.0 
HRMS calculated for C19H20NaO2+ [M+Na]+: 303.1356, Found: 303.1349. 
 
1HNMR (500 MHz; CDCl3): δ 7.11 (d, J = 7.9 Hz, 2H), 7.04 (d, J = 8.0 Hz, 2H), 6.90-6.85 (m, 
3H), 3.61 (s, 2H), 2.78 (t, J = 7.2 Hz, 2H), 2.73-2.72 (m, 2H), 2.33 (s, 3H), 2.21 (d, J = 1.7 Hz, 
3H). 
13CNMR (126 MHz; CDCl3): δ 207.6, 159.84 (JC-F = 243.18 Hz), 136.7, 136.235 (JC-F =3.78 
Hz), 131.25 (JC-F = 4.19 Hz), 130.9, 129.4, 129.2, 126.881 (JC-F= 7.81 Hz), 124.525 (JC-F= 17.13 
Hz), 114.73 (JC-F= 22.17 Hz), 77.3, 77.0, 76.7, 50.0, 43.4, 28.9, 21.0, 14.47 (JC-F= 3.53 Hz). 
HRMS calculated for C18H19FNaO+ [M+Na]+: 293.1312, Found: 293.1287. 
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1HNMR (500 MHz; CDCl3): δ 7.96-7.94 (m, 2H), 7.57-7.54 (m, 1H), 7.45 (t, J = 7.7 Hz, 2H), 
7.20 (td, J = 7.3, 2.7 Hz, 2H), 7.00-6.95 (m, 2H), 3.28 (t, J = 7.6 Hz, 2H), 3.05 (t, J = 7.6 Hz, 
2H). 
13CNMR (126 MHz; CDCl3): δ 199.0, 161.357 (JC-F= 244.44 Hz), 136.84 (JC-F= 3.15 Hz), 
136.75, 133.1, 129.79 (JC-F= 7.81 Hz), 128.6, 127.98, 127.94, 115.21 (JC-F= 21.17 Hz), 77.3, 
77.0, 76.7, 40.39 (JC-F= 0.63 Hz), 29.2. 
HRMS calculated for C15H13FNaO+ [M+Na]+: 251.0843, Found: 251.0845. 
 
1HNMR (500 MHz; CDCl3): δ 7.95 (d, J = 7.7 Hz, 2H), 7.55 (t, J = 7.2 Hz, 2H), 7.46 (t, J = 7.6 
Hz, 2H), 7.37 (d, J = 7.9 Hz, 2H), 3.33 (t, J = 7.5 Hz, 2H), 3.14 (t, J = 7.5 Hz, 2H). 
13CNMR (126 MHz; CDCl3): δ 198.5, 145.4, 136.6, 133.2, 128.72 (JC-F= 16.50 Hz), 128.66, 
128.0, 125.44 (JC-F= 3.78 Hz), 125.40, 125.35 (JC-F= 4.16 Hz), 39.8, 29.8 
HRMS calculated for C16H13F3NaO+ [M+Na]+: 301.0811, Found: 301.0818. 
 
1HNMR (400 MHz; CDCl3): δ  7.95-7.92 (m, 2H), 7.20 (dt, J = 6.6, 3.5 Hz, 2H), 6.99-6.91 (m, 
4H), 3.87 (s, 3H), 3.22 (t, J = 7.7 Hz, 2H), 3.03 (t, J = 7.7 Hz, 2H). 
13CNMR (126 MHz; CDCl3): δ 197.6, 163.5, 161.35 (JC-F= 244.44 Hz), 137.03 (JC-F= 3.15 Hz), 
131.0, 130.3, 129.79 (JC-F= 7.68 Hz), 115.20 (JC-F= 21.17 Hz), 113.7, 55.5, 40.07 (JC-F= 0.75 
Hz), 29.5 
HRMS calculated for C16H15FNaO2+ [M+Na]+: 281.0948, Found: 281.0955. 
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1HNMR (500 MHz; CDCl3): δ  7.85 (dt, J = 4.6, 2.4 Hz, 1H), 7.78 (d, J = 7.7 Hz, 2H), 7.48-7.46 
(m, 2H), 7.41 (dd, J = 8.2, 7.1 Hz, 1H), 7.31 (d, J = 6.9 Hz, 1H), 6.97 (td, J = 6.0, 2.6 Hz, 2H), 
6.87-6.83 (m, 2H), 4.06 (s, 2H), 2.79 (t, J = 7.3 Hz, 2H), 2.69 (t, J = 7.3 Hz, 2H). 
13CNMR (126 MHz; CDCl3): δ 207.6, 161.24 (JC-F= 244.31 Hz), 136.38 (JC-F= 3.15 Hz), 133.8, 
132.1, 130.7, 129.64 (JC-F= 7.81 Hz), 128.7, 128.21, 128.06, 126.5, 125.9, 125.5, 123.7, 115.03 
(JC-F= 21.04 Hz), 48.7, 42.8, 28.8 
HRMS calculated for C20H18FNaO+ [M+Na]+: 315.1156, Found: 315.1159. 
 
1HNMR (400 MHz; CDCl3): δ  7.08 (m, 2H), 7.01 (dd, J = 8.0, 5.6 Hz, 2H), 6.91 (m, 4H), 3.54 
(s, 2H), 2.94-2.87 (m, 2H), 2.53 (m, 1H), 2.32 (s, 3H), 1.07 (d, J = 6.3 Hz, 3H). 
13CNMR (126 MHz; CDCl3): δ 211.3, 161.42 (JC-F= 244.69 Hz), 136.5, 135.25 (JC-F= 3.40 Hz), 
130.5, 130.29 (JC-F= 7.94 Hz), 129.30, 129.26, 115.06 (JC-F= 21.04 Hz), 49.1, 47.0, 38.4, 21.0, 
16.8 
HRMS calculated for C18H19FNaO+ [M+Na]+: 293.1312, Found: 293.1117. 
 
1HNMR (400 MHz; CDCl3): δ  7.05 (m, 4H), 6.91 (m, 2H), 6.83 (d, J = 8.3 Hz, 2H), 3.78 (s, 
3H), 3.57 (s, 2H), 2.81 (t, J = 7.2 Hz, 2H), 2.71 (t, J = 7.4 Hz, 2H). 
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13CNMR (126 MHz; CDCl3): δ 207.6, 161.29 (JC-F= 244.44 Hz), 158.6, 136.53 (JC-F= 3.15 Hz), 
130.3, 129.68 (JC-F= 7.81 Hz), 129.4, 125.9, 115.11 (JC-F= 21.04 Hz), 114.14, 113.96, 55.2, 49.5, 
43.20 (JC-F= 0.75 Hz), 28.9. 
HRMS calculated for C17H17FNaO2+ [M+Na]+: 295.1105, Found: 295.1108. 
 
1HNMR (400 MHz; CDCl3): δ  7.96 (ddt, J = 8.9, 5.6, 2.9 Hz, 2H), 7.19 (td, J = 5.8, 2.7 Hz, 2H), 
7.13-7.08 (m, 2H), 6.96 (ddd, J = 10.5, 7.2, 2.8 Hz, 2H), 3.24 (t, J = 7.5 Hz, 2H), 3.03 (t, J = 7.5 
Hz, 2H). 
13CNMR (126 MHz; CDCl3): δ 197.4, 165.73 (JC-F= 255.53 Hz), 161.39 (JC-F= 244.69 Hz), 
136.70 (JC-F= 0.75 Hz), 133.20 (JC-F= 3.40 Hz), 130.61 (JC-F= 9.32 Hz), 129.79 (JC-F= 7.81 Hz), 
115.70 (JC-F= 21.92 Hz), 115.26 (JC-F= 21.17 Hz), 40.3, 29.2 
HRMS calculated for C15H12F2NaO+ [M+Na]+: 269.0748, Found: 269.0740. 
 
1HNMR (400 MHz; CDCl3): δ 7.43 (d, J = 8.3 Hz, 2H), 7.07 (dd, J = 8.3, 5.5 Hz, 2H), 7.01 (d, J 
= 8.2 Hz, 2H), 6.93 (t, J = 8.7 Hz, 2H), 3.60 (s, 2H), 2.84 (t, J = 7.2 Hz, 2H), 2.74 (t, J = 7.2 Hz, 
2H). 
13CNMR (126 MHz; CDCl3): δ 206.4, 161.37 (JC-F= 244.69 Hz), 136.32 (JC-F= 3.15 Hz), 132.8, 
131.8, 131.1, 129.71 (JC-F= 7.81 Hz), 121.1, 115.21 (JC-F= 21.17 Hz), 49.5, 43.6, 28.8. 
HRMS calculated for C16H14BrFNaO+ [M+Na]+: 343.0104, Found: 343.0106. 
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1HNMR (400 MHz; CDCl3): δ  7.56 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.3 Hz, 2H), 7.00 (d, J = 8.3 
Hz, 2H), 6.87 (d, J = 8.2 Hz, 2H), 3.60 (s, 2H), 2.80 (t, J = 6.8 Hz, 2H), 2.73 (t, J = 6.8 Hz, 2H). 
13CNMR (126 MHz; CDCl3): δ 206.2, 140.4, 137.5, 132.7, 131.8, 131.1, 130.4, 121.2, 91.2, 
49.5, 43.2, 29.1 
HRMS calculated for C16H15BrINaO+ [M+Na]+: 450.9165, Found: 450.9155. 
 
1HNMR (400 MHz; CDCl3): δ  7.77-7.74 (m, 2H), 7.70-7.68 (m, 2H), 7.56 (ddd, J = 7.7, 5.8, 1.7 
Hz, 1H), 7.48-7.40 (m, 4H), 7.23-7.21 (m, 2H), 7.03-7.01 (m, 2H), 3.62 (s, 2H), 2.94 (t, J = 7.4 
Hz, 2H), 2.80 (t, J = 7.4 Hz, 2H). 
13CNMR (126 MHz; CDCl3): δ 206.0, 196.2, 145.8, 137.6, 135.5, 132.7, 132.2, 131.8, 131.0, 
130.4, 129.9, 128.24, 128.19, 121.1, 49.4, 43.0, 29.5 
HRMS calculated for C23H19BrNaO2+ [M+Na]+: 429.0461, Found: 429.0465. 
 
1HNMR (400 MHz; CDCl3): δ  7.16 (m, 3H), 7.08 (m, 3H), 6.93 (m, 2H), 3.67 (s, 2H), 2.85 (t, J 
= 7.2 Hz, 2H), 2.71 (t, J = 7.2 Hz, 2H), 2.18 (s, 3H). 
OBr
I
OBr
O
O
F
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13CNMR (126 MHz; CDCl3): δ 207.14, 161.29 (JC-F= 244.44 Hz), 136.77, 136.49 (JC-F= 3.27 
Hz), 132.81, 130.45, 130.30, 129.69 (JC-F= 7.94 Hz), 127.33, 126.21, 115.10 (JC-F= 21.17 Hz), 
48.6, 43.3, 28.9, 19.6 
HRMS calculated for C17H17FNaO+ [M+Na]+: 279.1156, Found: 279.1158. 
 
1HNMR (400 MHz; CDCl3): δ  7.29-7.25 (m, 2H), 7.21-7.13 (m, 3H), 7.11-7.08 (m, 2H), 6.96-
6.92 (m, 2H), 2.87 (m, 4H), 2.72-2.66 (m, 4H). 
13CNMR (126 MHz; CDCl3): δ 208.9, 161.33 (JC-F= 244.69 Hz), 140.9, 136.59 (JC-F= 3.15 Hz), 
129.69 (JC-F= 7.81 Hz), 128.5, 128.3, 126.1, 115.19 (JC-F= 21.04 Hz), 44.5, 29.7, 28.85, 28.82 
HRMS calculated for C17H17FNaO+ [M+Na]+: 279.1156, Found: 279.1151. 
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